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ABSTRACT
Within the last thirty years, in the United States alone, the number of patients receiving
treatment for end-stage renal disease (ESRD) doubled (Centers for Disease Control and
Prevention [CDC], 2018b). Previous research has indicated lower quality of life in patients with
ESRD and has also shown further reduced quality of life with the presence of diabetes and
obesity (eg. Liu, Yeh, Weng, Bai, & Chang, 2017). The purpose of this study was to determine
the existence and nature of any relationship between quality of life and comorbidities of diabetes
mellitus and obesity in ESRD patients receiving hemodialysis treatment. Mean quality of life
scores were gathered from an electronic version of the WHOQOL-BREF survey distributed
through use of a social media platform, Facebook. The survey was available on multiple kidney
disease support group pages and the National Kidney Foundation Facebook page. Scores were
determined based on WHOQOL-BREF scoring instructions and mean quality of life scores were
then analyzed using unpaired t-tests across five domains: total, environmental factors, physical
health, psychological health, and social relationships. Results of the study concluded that
participants with comorbid diabetes reported decreased quality of life when compared to
participants with obesity alone, diabetes and obesity, and those without comorbid diabetes or
obesity. Participants with obesity reported lower quality of life scores when compared to
participants with no comorbidities. Finally, participants without diabetes and obesity (control
group) reported the highest quality of life scores across all domains. Findings from this study
could be utilized to aid in further research including exploration of glycemic control or severity
of obesity with regard to quality of life. More extensive research to determine causal factors with
regard to this population may help to improve understanding and promote interventions to
address quality of life in the ESRD population.
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Chapter One: Introduction
Introduction
Between 1990 and 2016, the number of end-stage renal disease patients receiving
treatment in the United States doubled (Centers for Disease Control and Prevention [CDC],
2018b). With ESRD gaining prevalence in the United States, recognizing which factors impact
quality of life among ESRD patients is important. Notably, research suggests that people with
ESRD undergoing hemodialysis have a poor quality of life (e.g., Liu, Yeh, Weng, Bai, & Chang,
2017). The focus of this study was to determine the impact of diabetes mellitus and obesity on
the quality of life of patients with ESRD who were receiving hemodialysis treatment. In doing
so, this study added to the current understanding of the factors that influence quality of life in
hemodialysis patients, thus guiding the ability to improve patient quality of life.
The remainder of Chapter One will discuss background information related to quality of
life in ESRD patients on hemodialysis, present the problem statement, distinguish the purpose
and significance of this study, identify research questions, discuss limitations and delimitations
of this study, and define important terms.
Background
End-stage renal disease is defined as chronic kidney disease with renal function less than
15% of the normal capacity, patients with previous kidney transplantation, or patients who are on
dialysis (Inker et al., 2014). Obesity is a significant risk factor for kidney disease, however,
diabetes mellitus is the leading cause of chronic kidney disease and subsequent progression to
ESRD (Mottl, Tuttle, & Bakris, 2019). Treatment options for ESRD include hemodialysis,
peritoneal dialysis, kidney transplantation, and conservative management (Medical Education
Institute, 2014). Of the available treatment options, 91.7% of ESRD patients choose
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hemodialysis for treatment (Medical Education Institute, 2014). Despite available treatment
options, kidney disease is the ninth leading cause of death in the United States (CDC, 2018a).
Research regarding the quality of life among ESRD patients is summarized below.
The available research suggests that patients with ESRD have a lower quality of life than
individuals without ESRD (e.g., Liu, Yeh, Weng, Bai, & Chang, 2017). Furthermore, ESRD
patients receiving hemodialysis have a lower quality of life than ESRD patients not receiving
hemodialysis (Schell, 2019). In addition, ESRD patients on hemodialysis with comorbid
conditions, such as diabetes mellitus and obesity, have a lower quality of life than ESRD
hemodialysis patients without comorbid conditions (Liu, Yeh, Weng, Bai, & Chang, 2017;
Mandoorah, Shaheen, Mandoorah, Bawazir, & Alshohaib, 2014). The available research does not
address the relative quality of life in patients with diabetes mellitus and ESRD, patients with
obesity and ESRD, or patients with diabetes mellitus, obesity, and ESRD. Research comparing
these groups is important as additional variables that affect quality of life in hemodialysis
patients may be identified, allowing for the creation of focused interventions to improve patient
quality of life. The next section defines the problem that this study will address.
Problem Statement
End-stage renal disease is a growing issue affecting hundreds of thousands of individuals
across the United States (CDC, 2018b). While there has been extensive research on the causes of
kidney disease and the outcomes of the various treatment options, a gap in research describing
the quality of life in ESRD patients with comorbid diabetes mellitus and obesity exists. Research
has already confirmed that ESRD patients who are undergoing hemodialysis have a decreased
quality of life (Liu, Yeh, Weng, Bai, & Chang, 2017; Beberashvili et al., 2019; Alhajim, 2017).
Quality of life is further decreased in the presence of comorbid conditions; however, the
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relationship between comorbid obesity, diabetes mellitus, or both on quality of life is unknown in
ESRD patients (Liu, Yeh, Weng, Bai, & Chang, 2017; Beberashvili et al., 2019; Alhajim, 2017).
In order to assess the quality of life of ESRD patients across the country, this study was
conducted through support groups found on Facebook, a social media platform. The study
focused on the evaluation of the quality of life among participants receiving hemodialysis
treatment. The participants’ quality of life was assessed and compared based on the presence or
absence of comorbid conditions (i.e., diabetes mellitus and obesity). The data collected from the
study was analyzed to determine which of the aforementioned comorbid conditions was most
associated with participant quality of life.
Purpose of the Study
The purpose of this study was to determine if the quality of life in ESRD patients
undergoing hemodialysis was more strongly related to comorbid obesity, comorbid diabetes
mellitus, or comorbid obesity and diabetes mellitus. This study compared the quality of life
among participants based on their comorbid conditions in order to understand the potential
influence of comorbid conditions on quality of life.
Significance of the Study
In 2016, there were 726,331 people in the United States receiving treatment for ESRD
(CDC, 2018b). The overall Medicare cost for patients with ESRD reached $35 billion in 2016,
which equals nearly $79,000 per person (CDC, 2018a). Due to the enormous financial and
morbidity burden of ESRD, evaluation of quality of life in this patient population is significant.
By determining which ESRD patients are at greater risk for poorer quality of life, supportive
efforts can be made to improve quality of life. Specifically, dialysis treatment centers and
healthcare providers will be able to use the information found in the study to better address
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patients with comorbid conditions and provide more focused resources to support and improve
quality of life. The research questions were directed at evaluating the quality of life in
participants with and without comorbid conditions.
Research Questions
To better understand the relationship between quality of life in ESRD patients receiving
hemodialysis and comorbid obesity and diabetes mellitus, this study was designed to answer the
following questions:
1. What relationship, if any, exists between diabetes mellitus and quality of life in ESRD
patients receiving hemodialysis treatment?
2. What relationship, if any, exists between obesity and quality of life in ESRD patients
receiving hemodialysis treatment?
3. Which comorbidity, diabetes mellitus or obesity, is more strongly related to quality of life
in ESRD patients who are receiving hemodialysis?
With the research questions in mind, the following paragraphs discuss delimitations, as well as
potential limitations, of conducting and evaluating the results of this study.
Limitations and Delimitations
As stated previously, this study focused on participants with ESRD who were being
treated with hemodialysis. Therefore, in order to control the focus of this study, the sample was
limited to the participant population on ESRD support group pages and the National Kidney
Foundation page. Participant quality of life was measured with a voluntary questionnaire
developed by the World Health Organization (WHO), known as the WHOQOL-BREF. The
WHOQOL-BREF measures quality of life with Likert scales and utilizes a set formulary to
interpret results (WHO, 2019; Bonomi, Patrick, Bushnell, & Martin, 2000). While the
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WHOQOL-BREF was not specifically created for evaluation of quality of life in ESRD patients,
the questionnaire has been used in numerous studies to reliably determine ESRD patient quality
of life (e.g., Alhajim, 2017). Therefore, the WHOQOL-BREF was an appropriate tool to measure
quality of life in this study. The population, location, and questionnaire were intentionally set in
order to narrow the scope of the study and for consistency of results. While delimitations
constrained the extent of the study, limitations may have unintentionally impacted the results of
this study.
Other factors may have unintentionally interfered with the evaluation of quality of life in
the selected patient population. Limitations included potential participant response bias to the
WHOQOL-BREF and sampling bias as the population was obtained solely through the social
media platform, Facebook. In order to limit the participant response bias to the
WHOQOL-BREF, the methodology reflects that the participants received no incentives for
taking the questionnaire and participants were encouraged to provide accurate information
without expectation of results. The available research indicates that quality of life decreases with
comorbid conditions; as researchers, the expectation of such results in the present study existed.
Utilizing the WHOQOL-BREF questionnaire ensured that questions were not written to benefit
or give disadvantage to groups within the population. The inclusion of complete questionnaires
guaranteed that results were representative of the study population. Researchers also understood
that the participant population may not have been an accurate representation of all ESRD patients
on hemodialysis. In order to set clear and consistent terminology throughout the remainder of
this study, the following section defines terms used for study description and evaluation.
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Definition of Terms
To ensure an accurate understanding and consistent interpretation of the study, contextual
definitions of common terms used throughout the study are presented in this section.
Participant: Participants within this study were ESRD patients who were receiving
hemodialysis treatment and were members of one of the the following Facebook groups: “Living
With Kidney Failure - End Stage Renal Disease (ESRD) Support Group”, “Hemodialysis
Support Group”, “Dialysis and Kidney Disease Support Group”, “Kidney Dialysis Support
Group”, or the Facebook page controlled by the National Kidney Foundation (NKF) at the time
of data collection.
Glomerular filtration rate: An estimation tool used to determine how quickly the kidneys
filter blood based on the Cockcroft-Gault equation and measured serum creatinine levels (Inker
& Perrone, 2019).
Albuminuria: Presence of protein, specifically albumin, in the urine (Albuminuria, 2019).
Chronic kidney disease (CKD): The presence of kidney damage markers or decreased
glomerular filtration rate for greater than three months (Inker et al., 2014).
End-stage renal disease (ESRD): Patients with kidney function below 15% normal
capacity, a previous kidney transplantation, or patients on dialysis treatment (Inker et al., 2014).
Comorbid conditions: The simultaneous presence of another medical condition in
addition to ESRD. Diabetes and obesity were the two primary comorbid conditions in the study.
Diabetes mellitus: Participants with previously diagnosed diabetes mellitus, either type 1
or type 2, were included in the diabetic comorbidity group.
Body Mass Index: A ratio of weight to height that is used to classify obesity.
Obesity: Body mass index greater than 30 kg/m2 (CDC, 2017).
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Hemodialysis: A renal replacement treatment option for ESRD that involves the removal
of patient blood, filtration of blood in a dialysis machine, and replacement of blood into the
patient (Rosenberg, 2019).
Quality of life: Quality of life is defined by the World Health Organization (2019) as “an
individual's perception of their position in life in the context of the culture and value systems in
which they live and in relation to their goals, expectations, standards and concerns”.
Participant Facebook group pages: “participant Facebook group pages” refers to the
Facebook groups used to post the survey, including “Living With Kidney Failure - End Stage
Renal Disease (ESRD) Support Group”, “Hemodialysis Support Group”, “Dialysis and Kidney
Disease Support Group”, and “Kidney Dialysis Support Group” Facebook pages, as well as a
Facebook page controlled by the National Kidney Foundation.
Control or control group: participants within the study without a reported diagnosis of
diabetes and BMI calculated from reported height and weight under the CDC outlined criteria for
obesity (BMI less than 30 kg/m2).
Conclusion
Chapter One discussed background information related to ESRD and quality of life, the
issues this study examined, the purpose, significance, research questions, limitations and
delimitations, and definitions of terms related to this study. The chapter addressed the importance
of understanding kidney disease and quality of life in ESRD patients, as ESRD is a large and
growing issue in the United States today (CDC, 2018b). Particularly, ESRD patients on
hemodialysis have a lower quality of life than the general population, especially when they have
a diagnosed comorbidity (i.e., diabetes mellitus or obesity) (e.g., Liu, Yeh, Weng, Bai, & Chang,
2017; Beberashvili et al., 2019; Alhajim, 2017). To fill in the gaps in current knowledge, this
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study examined whether comorbid obesity, comorbid diabetes mellitus, or comorbid obesity and
diabetes mellitus was more strongly related to a change in quality of life in ESRD patients on
hemodialysis. Chapter Two will review the literature regarding chronic kidney disease, ESRD,
and the available treatment options for kidney disease. Most importantly, the chapter includes a
summary of research related to the quality of life among those affected by kidney disease.
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Chapter Two: Literature Review
Introduction
The purpose of this literature review was to determine if comorbid diabetes mellitus or
obesity in patients with end-stage renal disease (ESRD) receiving hemodialysis has a negative
relationship with quality of life. The topic was addressed by examining the available research
regarding kidney disease in peer reviewed journals from scientific databases, textbooks, and
online resources. The following sections include: kidney function, chronic kidney disease (CKD)
and ESRD (e.g., risk factors and complications), treatment options for ESRD, and the quality of
life of people receiving hemodialysis. Ultimately, this review assesses quality of life in ESRD
patients who are receiving hemodialysis.
Kidney Function
In thirty minutes, healthy kidneys can filter all of the blood in the body (CDC, 2018a).
Through the excretion of excess fluid, the kidneys are able to maintain blood pressure and
regulate electrolyte balance within the body (CDC, 2018a). Nephrons are the functional units of
the kidneys that are responsible for resorption of fluid and solutes, as well as excretion of waste
products (Costanzo, 2018). Each kidney consists of approximately one million nephrons that
work together to filter blood (Costanzo, 2018). Blood enters the kidneys through the renal
arteries where the vessels continue to branch until reaching the smallest vessel size as arterioles.
The afferent arterioles supply blood to the glomerular capillaries where filtration begins
(Costanzo, 2018). The arterioles leave glomeruli as efferent arterioles to supply blood to
nephrons where solutes and water are further reabsorbed or secreted (Costanzo, 2018). Waste
products are excreted into tubules that lead to minor and major calyces, which are extensions of
the ureters (Costanzo, 2018). The ureters extend to the bladder for the storing and eventual
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elimination of waste. When the kidneys are not functioning well due to disease or damage, they
cannot filter blood as efficiently (Costanzo, 2018).
As blood filtration becomes less efficient, excess fluid begins to accumulate in the body
eventually leading to health issues including cardiovascular disease or stroke (CDC, 2018a). As
the disease progresses, patients are at an increased risk of infections and can also experience a
loss of appetite, anemia, lower quality of life, or depression (CDC, 2018a). The kidneys are
responsible for maintaining fluid levels, removing wastes, and reabsorbing nutrients from the
blood. Increased fluid retention, as well as build up of bodily wastes and toxins associated with
kidney malfunction, negatively impacts the overall health of all organ systems (CDC, 2018a).
Glomerular filtration rate. Estimated glomerular filtration rate (GFR) is a tool used to
monitor the filtration of blood through the kidneys. In a healthy kidney, GFR is equal to the sum
of the activity of all the nephrons within both kidneys (Inker & Perrone, 2019). A healthy kidney
filters approximately 180 liters of blood plasma in a day, which amounts to 125 milliliters per
minute (Inker & Perrone, 2019). GFR varies by age, sex, and the size of the body, with young
women usually filtering 120 milliliters per minute and young men averaging 130 millimeters per
minute (Inker & Perrone, 2019). As age increases, GFR tends to decrease (Inker & Perrone,
2019). When the kidneys are diseased or damaged, the number of functional nephrons is reduced
(Inker & Perrone, 2019). With mild damage or early disease states, the remaining nephrons can
adapt and maintain the total GFR, however, as the disease progresses, GFR is drastically reduced
(Inker & Perrone, 2019). GFR can be estimated by creatinine clearance calculated with the
Cockcroft-Gault equation and serum creatinine levels (Inker & Perrone, 2019). The average
serum creatinine level is 1.13 mg/dL and 0.93 mg/dL in men and women, respectively (Inker &
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Perrone, 2019). By measuring the serum creatinine levels, GFR can be estimated and used to
evaluate the severity of kidney disease.
Classification of Chronic Kidney Disease
In 2002, the National Kidney Foundation set guidelines regarding the classification of
CKD through the Kidney Disease Outcomes Quality Initiative (KDOQI) (Levey & Inker, 2018).
Chronic kidney disease is defined as the presence of kidney damage markers or decreased GFR
for greater than three months (Inker et al., 2014). The KDOQI has recommended that CKD
staging includes the cause of disease, GFR category, and albuminuria category (Inker et al.,
2014). The cause of kidney disease is determined by identifying which portion of the kidney is
damaged and evaluating for the presence of systemic disease markers (Inker et al., 2014). While
the cause of disease is an important consideration in staging, estimated GFR is the most utilized
staging criteria for CKD.
Glomerular filtration rate can be categorized into G1, G2, G3a, G3b, G4, and G5
subdivisions with G5 being the most severe functional deficit (Inker et al., 2014). Specific
markers of kidney damage include albuminuria, urine sediment abnormalities, electrolyte
abnormalities due to tubular disorder, abnormal histology, structural abnormalities on imaging,
and history of a kidney transplant (Inker et al., 2014). Albuminuria occurs when the kidneys are
not functioning correctly and proteins begin to escape the bloodstream and enter the urine
(“Albuminuria”, 2019). The presence of protein in the urine indicates disease or damage of the
kidneys requiring further evaluation and possible treatment (“Albuminuria”, 2019). Together,
these criteria define CKD and allow standardized patient assessment and diagnosis.
If a patient presents with GFR within categories G3 through G5 and/or an elevated
albuminuria for three or more months, diagnosis of CKD is appropriate. General prognosis can

22
be determined when the albuminuria category is crossed with the GFR category (Inker et al.,
2014). Table 1 indicates the ranges of GFR for each stage of kidney damage, eventually leading
to kidney failure at a GFR less than 15 ml/min/1.73 m2. As discussed previously, the average
GFR for a young person is approximately 125 ml/min/1.73 m2 while the expected GFR for an
older individual is reduced to 90 ml/min/1.73 m2 (Inker & Perrone, 2019). Thus, less than 15%
of normal kidney function qualifies as ESRD.
Table 1.
Glomerular Filtration Rate Categories in CKD (Inker et al., 2014).
GFR Category

GFR (ml/min/1.73 m2)

Terms

G1

≥ 90

Normal to high

G2

60-89

Mildly decreased

G3a

45-59

Mildly to moderately decreased

G3b

30-44

Moderately to severely decreased

G4

15-29

Severely decreased

G5

<15

Kidney failure

As kidney damage increases, the amount of protein in the urine (i.e., albuminuria) also
increases. Table 2 indicates the categories of albuminuria and cut off lab values related to the
levels of severity. Albuminuria levels that are substantially increased for a prolonged period of
time are associated with greater risk for worsening GFR, ESRD, and cardiovascular disease
(Mottl, Tuttle, & Bakris, 2019).
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Table 2.
Albuminuria Categories in CKD (Inker et al., 2014).
Category

AER (mg/24 hours)

Terms

A1

<30

Normal to mildly increased

A2

30-300

Moderately Increased

A3

>300

Severely Increased

Causes and Risk Factors of Chronic Kidney Disease
Many factors influence the development of CKD and the subsequent progression to
ESRD. The following sections include the available research that describes the relationship
between CKD, the progression to ESRD, and the most common risk factors including genetic
predisposition, diabetes mellitus, and obesity.
Genetic predisposition. While lifestyle plays a major role in the development of kidney
disease, genetic predisposition is also a factor for many people with kidney disease. For example,
variation in the apolipoprotein L1 (APOL1) gene is thought to be responsible for 70% of all
CKD in the nondiabetic African American population (Witasp et al., 2012). A prospective cohort
study of 3,067 African American adults without CKD were evaluated for the presence of risk
alleles in the APOL1 gene (Foster et al., 2012). Forty-three percent of those participants had one
risk allele and 13% had two risk alleles (Foster et al., 2012). The participants with two risk
alleles were at a 1.51 greater risk of CKD than those with one risk allele (Foster et al., 2012).
The participants with two risk alleles also had an increased risk of ESRD with a 1.92 risk ratio
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when compared to those with one risk allele of the APOL1 gene (Foster et al., 2012). In addition
to the APOL1 gene, congenital anomalies increase the risk of developing CKD.
While the focus of the review is on adults and their risk factors for kidney disease,
genetic or developmental disorders also increase the risk of disease in children and adolescents.
Between 30% and 50% of all ESRD cases in children are caused by congenital anomalies of the
kidney and urinary tract (CAKUT), while the majority of cases in adults are caused by diabetes
mellitus (Rosenblum, 2017). In the following sections, diabetes mellitus and obesity are
discussed in relation to adult populations exclusively.
Diabetes Mellitus. Type 1 and type 2 diabetes mellitus are leading causes of CKD and
progression to ESRD worldwide (Mottl, Tuttle, & Bakris, 2019). Fifty percent of all cases of
ESRD in the United States are attributed to diabetes mellitus with the number continuing to rise
due to the increased prevalence of diabetes mellitus in the population (Mottl, Tuttle, & Bakris,
2019). Approximately 40% of those with type 2 diabetes mellitus develop albuminuria, increased
blood pressure, and declining kidney function consistent with diabetic kidney disease (Kasper et
al., 2004). Specifically, prolonged hyperglycemia and insulin resistance associated with diabetes
mellitus results in inflammation and fibrosis of the renal tissues (Mottl & Tuttle, 2019). While
commonly associated with uncontrolled hyperglycemia, kidney disease also occurs in diabetic
patients with well-controlled blood glucose levels (Mottl, Tuttle, & Bakris, 2019). In the early
stages of diabetes mellitus, activation of the renin-angiotensin-aldosterone system (RAAS)
initiates increased plasma flow and filtration fraction resulting in an elevated GFR (Mottl &
Tuttle, 2019). Over time, GFR decreases due to progressive inflammation and eventual fibrosis
of tissues, causing kidney disease (Mottl, Tuttle, & Bakris, 2019). The rate at which the
estimated glomerular filtration rate declines is prognostic for ESRD and mortality in diabetic
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kidney disease (Mottl, Tuttle, & Bakris, 2019). Studies across the world have been done to
compare incidence of CKD and ESRD in diabetic and nondiabetic populations.
One cohort study done in the United States, which included 932 patients with type 1
diabetes mellitus who were diagnosed between 1965 and 1980, showed a 5.5% incidence of
ESRD in 20 years and a 27% incidence in 40 years (Mottl, Tuttle, & Bakris, 2019). These results
were compared to a cohort of 7,871 patients with type 1 diabetes mellitus in Norway who were
diagnosed between the years of 1971 and 2012 (Mottl, Tuttle, & Bakris, 2019). The 20 year
incidence rate of ESRD was 0.7% while the 40 year incidence was 5.3% among the diabetic
patients in Norway (Mottl, Tuttle, & Bakris, 2019). While many factors may have been
influential in the difference in disease progression between the United States and Norway, two of
the major factors included glycemic and blood pressure control (Mottl, Tuttle, & Bakris, 2019).
An additional prospective cohort study done in 2004 evaluated the estimated GFR of 227
Caucasian type 2 diabetic patients with kidney disease over the course of three or more years
(Kasper et al., 2004). Participants within the study that had higher baseline blood pressure,
hemoglobin A1c, and age were found to have more rapid decline in GFR over the course of the
study (Kasper et al., 2004). Patients without diabetic retinopathy, which is an indicator of end
organ damage, had a GFR decline of only 2.6 ml/min/1.73 m2 compared to a GFR decline of 5.5
ml/min/1.73 m2 in patients with diabetic retinopathy (Kasper et al., 2004). The study found that
the correction of modifiable risk factors including albuminuria, hemoglobin A1C, systolic blood
pressure, and heavy smoking improved outcomes in type 2 diabetic patients with kidney disease
(Kasper et al., 2004). While diabetes mellitus is the most heavily studied and known cause of
kidney disease, obesity has also been evaluated as a potential risk factor and source of kidney
damage and disease.
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Obesity. Another known risk factor for kidney disease is obesity. A body mass index
(BMI) between 25 and 30 kg/m2 is classified as overweight and a BMI over 30 kg/m2 meets
criteria for obesity (CDC, 2017). Obesity, specifically abdominal obesity, is highly associated
with the presence and severity of comorbidities that place an increased demand on the kidneys,
potentially leading to CKD and ESRD. A systematic review evaluating diabetic patients with
chronic kidney disease stages three to five, discussed obesity as an independent risk factor for
kidney disease (Van Huffel et al., 2014). The review reported that weight loss through bariatric
surgery improved GFR in obese patients with CKD (Van Huffel et al., 2014).
An article in the Canadian Journal of Kidney Health and Disease summarized various
studies that found obesity to be associated with proteinuria, low GFR, and higher incidence of
ESRD (Kovesdy, Furth, & Zoccali, 2017). While obesity is known to increase risk for
development of conditions that damage the kidneys, such as diabetes mellitus and hypertension,
increased adiposity is also thought to directly damage the kidneys through the production of
leptin, resistin, and adiponectin (Kovesdy, Furth, & Zoccali, 2017). Proposed mechanisms
damage the kidneys through inflammation, oxidative stress, abnormal lipid metabolism,
activation of the renin-angiotensin-aldosterone system, and increased insulin production and
resistance (Kovesdy, Furth, & Zoccali, 2017).
A review of 25 cohort studies, three cross-sectional studies, and 19 case-control cases
was done to determine how obesity and kidney disease relate to one another (Wang, Song,
Caballero, & Cheskin, 2008). Overweight patients (BMI 25-30 kg/m2) were found to have a 1.4
relative risk of developing kidney disease, while patients with obesity had a 1.83 relative risk
when compared to those of a normal body weight (BMI 18.5-24.9kg/m2) (Wang, Song,
Caballero, & Cheskin, 2008). A cohort study of 74,989 patients who were followed for 21 years

27
showed that patients with both obesity and prehypertension had an increased risk for developing
kidney disease (Munkhaugen, Lydersen, Wideroe, & Hallen, 2009). The studies utilized in this
review evaluated patient BMI rather than waist circumference, however, waist circumference is a
better measure of abdominal obesity.
Other causes and risk factors of Chronic Kidney Disease. As previously shown, any
behaviors that lead to the development of diabetes mellitus, obesity, or hypertension are known
to be risk factors for kidney disease. For example, smoking and alcohol use are associated with
an increased risk of kidney disease (Shankar, Klein, & Klein, 2006). A longitudinal cohort study
done in Wisconsin followed 3,392 participants without CKD for five years (Shankar, Klein, &
Klein, 2006). The study found that three percent, or 114 participants, developed CKD with a
GFR of less than 60 mL/min/1.73 m2 (Shankar, Klein, & Klein, 2006). The study found an
increased risk of CKD in the participants who either smoked or drank heavily (i.e., greater than 4
drinks per day) and a dramatically increased risk in those who both smoked and drank heavily at
the time of the study (Shankar, Klein, & Klein, 2006).
While diabetes mellitus accounts for a large majority of cases, other causes of CKD and
ESRD include polycystic kidney disease, pyelonephritis (i.e., recurrent kidney infection),
glomerulonephritis (i.e., glomerular inflammation), interstitial nephritis (i.e., kidney tubule or
surrounding inflammation), and prolonged obstruction of the urinary tract by kidney stones,
cancer, or an enlarged prostate (Mayo Clinic Staff, 2019). These conditions can progress causing
kidney damage within months or years (Mayo Clinic Staff, 2019). When multiple conditions and
risk factors are present, patients are at an even higher risk for developing severe CKD and ESRD
(Mayo Clinic Staff, 2019).
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Prevalence of Chronic Kidney Disease and End-Stage Renal Disease
The CDC (2018a) reports that kidney disease is the ninth leading cause of death in the
United States. The National Health and Nutrition Examination Survey done from 2011 to 2014
evaluated the prevalence of adult CKD in the United States (Obrador, 2018). The survey found
that 7.2% of the population, or 8.3 million people, had CKD with a GFR of less than 60
mL/min/1.73 m2 indicating stage three through stage five CKD (Obrador, 2018). According to
the CDC (2018a), more than one in seven adults have CKD in the United States. A meta-analysis
of 44 countries indicated a 13.4% prevalence of CKD globally, while another meta-analysis
showed a 10.4% prevalence in men versus an 11.8% prevalence in women (Hill et al., 2016;
Mills et al., 2015).
Complications of Kidney Disease
As renal disease progresses, patients often experience symptoms including nausea,
vomiting, loss of appetite, fatigue, weakness, difficulty sleeping, altered focus, muscle cramping,
lower extremity swelling, chest pain, and shortness of breath due to the dangerous build up of
fluid and waste in the body (Mayo Clinic Staff, 2019). When kidney function meets the criteria
for CKD or the kidneys are not meeting the demands of the body, treatment is required to
maintain the health of the remaining organ systems (Mayo Clinic Staff, 2019). The early stages
of CKD can be managed with medications, however when symptoms severely interfere with
daily life, more invasive treatments are required. The next section discusses treatment options
specifically for ESRD including hemodialysis, peritoneal dialysis, kidney transplant, and
conservative management.
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Treatment Options for End-Stage Renal Disease
Early detection and referral to a nephrologist is crucial in decreasing morbidity and
mortality of patients suffering from ESRD (Rosenberg, 2019). Early intervention allows for
patients to begin accepting their diagnosis, evaluating treatment options, and obtaining prompt
vascular or peritoneal access for treatment (Rosenberg, 2019). Nephrologists educate patients
and their families on the existing options for renal replacement therapy (RRT) and guide patients
in selecting the best individual treatment option (Rosenberg, 2019). A number of treatment
options are currently available for the treatment of ESRD including hemodialysis, peritoneal
dialysis, kidney transplantation, and conservative management (Rosenberg, 2019). Each
treatment option will be discussed in detail with a specific focus on hemodialysis.
Hemodialysis. Hemodialysis is the most popular option for renal replacement treatment
accounting for 91.7% of ESRD patient treatment (Medical Education Institute, 2014).
Hemodialysis includes removal of blood from the patient’s vessel, filtration of the blood through
a dialysis machine, and eventual return of blood to the patient’s body in a continuous process
(Medical Education Institute, 2014). In order to remove blood from the patient for filtration,
vascular access must be obtained. An arteriovenous fistula, arteriovenous graft, or a tunneled
catheter may be used for vascular access (Rosenberg, 2019). Maintaining healthy vascular access
is crucial to patient survival on hemodialysis; when all options for access are exhausted,
hemodialysis cannot continue and without treatment the patient will die (Medical Education
Institute, 2014). A team of direct patient care staff including patient care technicians, nurses, and
doctors are responsible for administering hemodialysis treatment during the patient's scheduled
session, typically at an outpatient dialysis center (Medical Education Institute, 2014).
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A typical hemodialysis treatment regimen includes three sessions per week lasting
between three and five hours each. Patient attendance to all hemodialysis treatment sessions is
crucial. One retrospective cohort study found that missing or shortening dialysis treatments is
linked to severe electrolyte imbalance, fluid overload, and life threatening arrhythmias
(Chamberlain, Hunt, Bashir, & Zager, 2012). The cardiovascular symptoms associated with
missed treatments lead to an increase in hospitalizations and increased cardiovascular mortality
among ESRD patients (Chamberlain et al., 2012).
Unfortunately, despite consistent attendance to treatment, complications during
hemodialysis arise for most patients. Common complications of hemodialysis include
hypotension, nausea, muscle cramps, and pruritus (Medical Education Institute, 2014). While
serious complications are uncommon, air embolism, anaphylaxis, and cardiac arrest are all
possible complications of hemodialysis (Medical Education Institute, 2014). Despite the
associated risks, patients with ESRD rely heavily on hemodialysis as survival is dependent upon
the removal of excess fluid and toxins from the bloodstream.
Hemodialysis is the most common treatment option for ESRD patients, however, there
are limitations associated with the treatment (Medical Education Institute, 2014). Functioning
kidneys can remove all excess fluid from the body, whereas hemodialysis can only remove a
limited amount of fluid with each treatment (Medical Education Institute, 2014). Hemodialysis
can remove some bodily waste and phosphorus while controlling blood pressure through fluid
removal and sodium balance, however, not as efficiently as functional kidneys (Medical
Education Institute, 2014). Due to treatment limitations, patients must limit fluid gains between
each treatment while also maintaining a high protein, low sodium, and low potassium diet. In
addition, failing kidneys cannot produce erythropoietin, a hormone that initiates red blood cell
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production (Medical Education Institute, 2014). Therefore, in order to avoid anemia,
supplemental erythropoietin shots are given to ESRD patients during hemodialysis treatment
(Medical Education Institute, 2014). Although a popular and beneficial treatment option for
patients with ESRD, hemodialysis is not as efficient as normal functioning kidneys.
Peritoneal dialysis. Peritoneal dialysis (PD) is a treatment option utilized by patients
who wish to “fit their treatment into their lives – not fit their lives into a center’s treatment”
(Medical Education Institute, 2014, p. 35). Peritoneal dialysis is a feasible treatment option for
patients who can administer their own care, continue to work, and want fewer dietary restrictions
(Medical Education Institute, 2014). With two PD treatment options available, patients can
choose between continuous ambulatory peritoneal dialysis (CAPD) or continuous cycling
peritoneal dialysis (CCPD) depending upon which treatment option fits better into their lifestyle
(Medical Education Institute, 2014). Patients who are eligible for peritoneal dialysis often suffer
from fewer comorbidities when compared to patients on hemodialysis (Burkart, 2019). In 2009,
when considering the total number of patients receiving dialysis, approximately six percent were
receiving peritoneal dialysis while 94% were receiving hemodialysis (Burkart, 2019). Peritoneal
dialysis shows some short-term benefits in first year survival when compared to hemodialysis
(Burkart, 2019). In patients with comorbidities (i.e., diabetes mellitus or hypertension), PD
shows no benefit to first year survival, with comparable or even decreased survival after the first
year, when compared to hemodialysis (Burkart, 2019). Peritoneal dialysis is an option for
patients who seek independence in their treatment and lifestyle. Despite the added independence,
PD does not show substantial benefit when compared to hemodialysis.
Transplantation. According to Rosenberg (2019), “kidney transplantation is considered
the treatment of choice for ESRD”. A number of factors are evaluated when determining if a
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patient is a candidate for transplantation (Rossi & Klein, 2019). Although kidney transplantation
is the gold standard treatment, of the 100,000 people who are diagnosed with ESRD each year,
only about 15,000 receive transplants (Medical Education Institute, 2014). According to Rossi
and Klein (2019), kidney transplantation is a selective process with absolute contraindications
including active infection, malignancy, substance abuse, noncompliance to current treatment, and
significantly decreased life expectancy. Initial screening for transplantation candidates includes
evaluating labs (e.g., blood type, serological testing, human leukocyte antigen) and imaging (e.g.,
chest x-ray, electrocardiogram, and ultrasound) (Rossi & Klein, 2019). In addition to labs and
imaging, patients seeking transplantation are extensively evaluated for comorbidities including
diabetes mellitus, hypertension, peripheral vascular disease, angina, cardiomyopathy,
hematological disorders, and obesity (Rossi & Klein, 2019). Patients that meet kidney transplant
criteria wait for a kidney to become available.
Three options are available for kidney transplantation: a kidney from a living blood
relative, a kidney from a living, non-blood relative, and a kidney from a deceased donor
(Medical Education Institute, 2014). Kidney transplantation is likely a more permanent treatment
option when compared to dialysis, but is not a cure for ESRD as kidney rejection is always a
possibility (Medical Education Institute, 2014). According to the Medical Education Institute
(2014), 92% of deceased donor transplant kidneys are functioning one year after transplant, 71%
are functioning after five years, and only 45% are functioning after 10 years. If the kidney
transplant fails, patients are reassigned a number on the transplant list and begin treatment with
PD or hemodialysis as they wait for another kidney (Medical Education Institute, 2014).
Conservative management. Conservative care is a treatment option chosen by patients
who do not wish to undergo dialysis or transplantation (Schell & Arnold, 2019). Often patients
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who elect this method of care suffer from advanced comorbidities and want to shift their focus
from intensive medical care to managing and maintaining a more optimal quality of life (Schell
& Arnold, 2019). Although an option for every patient with ESRD, according to the Renal
Physician Association, conservative care is most often considered for patients over 75 years of
age who have two or more the following qualities indicative of a poor prognosis: “impaired
functional status”, “severe malnutrition”, “multiple comorbidities”, or “positive response to the
question: ‘No, I would not be surprised if this patient died within the next year.’” (Schell &
Arnold, 2019, para. 11). With a median survival of six months, conservative care focuses on the
management of symptoms, blood pressure, and optimizing quality of life (Schell & Arnold,
2019).
Quality of Life
Quality of life is an ambiguous term that describes the effects of multiple objective and
subjective constructs on a person’s wellbeing, including but not limited to: self-esteem,
self-efficacy, social values and beliefs, relationships, aspirations, life expectations, physical
functionality, independence, and psychological health (Carr, Higginson, & Robinson, 2003).
The World Health Organization (WHO) (2019, p. 1) defined quality of life as “an individual's
perception of their position in life in the context of the culture and value systems in which they
live and in relation to their goals, expectations, standards and concerns”. A definitive tool for
measuring quality of life is not currently used, but many resources exist for evaluation. For
example, the WHO developed the WHOQOL-100 and an abbreviated version, the
WHOQOL-BREF, which are questionnaires that measure quality of life reliably and accurately
across cultures (WHO, 2019).
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Using tools like the WHOQOL-100, quality of life is often assessed in healthcare settings
to help determine patients’ well-being and assess their functional status (Carr, Higginson, &
Robinson 2003). A gold standard measurement tool has not been established for measuring
quality of life in ESRD patients (Holley, 2019). Current recommendations for assessing patients
with kidney disease involve quality of life assessment at the time of CKD diagnosis and routine
reassessment at the time of symptom evaluation, throughout the progression of the disease, and
until the death of the patient (Holley, 2019). The information gathered from these studies reveals
important insights into the lives of CKD and ESRD patients, showing primarily that patients with
CKD or ESRD have a decreased quality of life (Holley, 2019).
Research supports the idea that people with kidney disease have a lower quality of life
than those without kidney disease (e.g., Liu, Yeh, Weng, Bai, & Chang, 2017). Notably, patients
with ESRD often experience complications such as depression, sexual dysfunction, decreased
functional status, and low employment rates, all of which may impact quality of life (Holley,
2019). End-stage renal disease patients receiving hemodialysis may also experience symptom
burdens, such as being undertreated and feeling under-recognized, which may also negatively
impact quality of life (Koncicki, 2018; Schell, 2019). In one study, life satisfaction in ESRD
patients decreased significantly during initiation of hemodialysis and remained low throughout
the remainder of the patients’ lives (Schell, 2019).
Many factors have been measured that correlate to quality of life in ESRD patients. Age,
for example, has been linked to quality of life in these patients (e.g., Alhajim, 2017), but current
research has not determined age alone as a scientific predictor of life quality (Madhan, 2008).
However, research has suggested that frailty (commonly associated with geriatric patients) in
ESRD is positively correlated with mortality and negatively correlated with quality of life and
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functional status in patients receiving hemodialysis (Holley, 2019; Hornik & Duwala, 2019).
Relatedly, one study showed that after initiation of hemodialysis, geriatric patients spent half of
their remaining life in treatment or in the hospital, which may significantly impact their quality
of life (Koncicki, 2018).
The health of end-stage renal disease patients is also related to quality of life. Improved
mental and physical health have been shown to positively predict quality of life in hemodialysis
patients (Madhan, 2008). In terms of physical health, studies have shown that low-intensity
exercise can improve functional status and quality of life in ESRD patients on hemodialysis
(Manfredini et al., 2017; Hornik & Duwala, 2019). Furthermore, decreased physical activity in
hemodialysis patients was found to increase anxiety in these patients (Hornik & Duwala, 2019).
In terms of mental health, one study revealed that patients with depression prior to
starting hemodialysis had a mortality rate three times higher than those without depression
(Chiang, Guo, Livneh, Lu, Yen, & Tsai, 2015). Another study showed that patients with kidney
disease, especially those with ESRD recieving hemodialysis, are at a significantly higher risk of
committing suicide than people without kidney disease (Liu, Yeh, Weng, Bai, & Chang, 2017).
Kidney disease patients are four times more likely to commit suicide during the initiation of
hemodialysis than at any other point during their disease progression (Liu, Yeh, Weng, Bai, &
Chang, 2017). Thus, promoting and managing mental and physical health in hemodialysis
patients is important in quality of life outcomes.
Comorbid health issues also impact the lives of ESRD patients. For example, diabetes
mellitus, hypertension, cardiomyopathy, and arthropathies, have been shown to reduce quality of
life in patients with kidney disease (Liu, Yeh, Weng, Bai, & Chang, 2017; Mandoorah, Shaheen,
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Mandoorah, Bawazir, & Alshohaib, 2014). Relatedly, patients with comorbidities spend more
time hospitalized, which decreases life quality (Koncicki, 2018).
In the literature, diabetes mellitus is correlated with a decrease in quality of life among
ESRD patients (e.g., Alhajim, 2017). Using the WHOQOL-BREF to measure quality of life in
patients with kidney disease receiving hemodialysis, one study found that comorbid diabetes
mellitus, specifically, was related to decreased quality of life (Alhajim, 2017). Alhajim (2017)
examined 104 ESRD patients who had been on hemodialysis for at least three months, of which
34% had diabetes mellitus. The patients with diabetes mellitus had a reduced quality of life
compared to the patients without diabetes mellitus (Alhajim, 2017). Additionally, research by
Zimbudzi et al. (2016), which used the Kidney Disease Quality of Life questionnaire to measure
quality of life in 308 ESRD patients, suggested that patients with diabetes mellitus who
developed kidney disease, but were not yet receiving hemodialysis, had a lower quality of life
than patients receiving hemodialysis with kidney disease alone.
Obesity is another factor related to quality of life in kidney disease patients. For example,
one systematic review concluded that obesity puts individuals at risk for not only developing
CKD, but also faster disease progression (Van Huffel et al., 2014). According to another
systematic review, morbidly obese ESRD patients receiving hemodialysis have lower quality of
life than non-obese patients due to multiple factors such as difficulty with atrial venous fistula
placement, longer duration of treatment, more frequent dialysis visits, difficulty with
transportation, and inability to maneuver clinic spaces (Turgut & Abdel-Rahman, 2017).
Primarily, “[t]his increase in time as well as frequency of dialysis impacts negatively on the
quality of lives of these patients'' (Turgut & Abdel-Rahman, 2017).

37
Additionally, a Danish study looked at two groups of ESRD patients receiving
hemodialysis, one group in 2002 and one group in 2015 (Knudsen, Eidemak, & Molsted, 2016).
The study showed that during the 13-year period between groups, there was a significant
increase in mean BMI and percentage of overweight or obese patients in the 2015 group and the
quality of life decreased accordingly (Knudsen, Eidemak, & Molsted, 2016). Relatedly, another
cross-sectional study, which measured quality of life in hemodialysis patients and compared
patients based on their level of obesity, showed that obesity in ESRD patients on hemodialysis
was associated with decreased quality of life (Beberashvili et al., 2019). Waist circumference
was a better indicator of decreased quality of life than body mass index, where obesity was
defined as a waist circumference greater than 88 cm in women and greater than 102 cm in men
(Beberashvili et al., 2019). Ultimately, the available research suggests that both diabetes mellitus
and obesity are correlated with poorer quality of life.
Conclusion
An overview of the available literature indicates that the presence of comorbid
conditions, specifically diabetes mellitus and obesity, negatively predicts outcomes of CKD and
ESRD. While studies have identified that diabetes mellitus and obesity both influence quality of
life individually, research has not shown if those with obesity have a poorer quality of life than
those with diabetes mellitus or vice versa. In addition, the available studies have not indicated if
those with both obesity and diabetes mellitus have a poorer quality of life than those with only
one of the comorbid conditions. Using an online version of the WHOQOL-BREF within a
Facebook support group, this study measured and compared quality of life in ESRD patients on
hemodialysis who: (1) did not have diabetes mellitus and were not obese, (2) had diabetes
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mellitus but were not obese, (3) were obese but did not have diabetes mellitus, and (4) were both
diabetic and obese. The methodology of this study is discussed in Chapter Three.
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Chapter Three: Methodology
Introduction
The purpose of this study was to examine the relationship between quality of life of
patients with end-stage renal disease (ESRD) on hemodialysis and respective comorbidities of
diabetes mellitus and obesity. The research questions this study evaluated were:
1. What relationship, if any, exists between diabetes mellitus and quality of life in ESRD
patients receiving hemodialysis treatment?
2. What relationship, if any, exists between obesity and quality of life in ESRD patients
receiving hemodialysis treatment?
3. Which comorbidity, diabetes mellitus or obesity, is more strongly related to a decreased
quality of life among ESRD patients who are receiving hemodialysis?
This chapter describes the study design, population, procedures, data collection, limitations, and
delimitations of this study.
Study Design
This study was a quantitative, descriptive study that utilized a survey, the
WHOQOL-BREF translated into an online Qualtrics format (see Appendix A), to analyze the
relationship between quality of life of participants with ESRD receiving hemodialysis and the
comorbidities of obesity and diabetes. The WHOQOL-BREF was chosen to evaluate participant
quality of life because the tool is a reliable indicator of quality of life across cultures. In addition,
the tool was designed with a scoring algorithm that was used in this study to analyze the data.
The goal of this study was to determine if a relationship exists between the independent
variables of quality of life and participant comorbidities of diabetes and obesity. Five categories
of participant quality of life (i.e., total, physical health, psychological health, environmental
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factors, social relationships) were numerically scored using the survey tool, which were
evaluated across comorbidity groups to determine if any relationship existed. In addition,
analysis of demographic categories including age, gender, country of residence, marital status,
and education level were included to both identify significant relationships and to account for
potential confounding variables.
Population
The prevalence of ESRD is rapidly growing in the United States; however, there is little
research describing the quality of life of ESRD patients. The data for this study was collected
from end stage renal disease (ESRD) patients who were receiving hemodialysis treatment at the
time of data collection. Participants were recruited through the “Living With Kidney Failure End Stage Renal Disease (ESRD) Support Group”, “Hemodialysis Support Group”, “Dialysis
and Kidney Disease Support Group”, and “Kidney Dialysis Support Group” Facebook pages, as
well as a Facebook page controlled by the National Kidney Foundation (NKF). These Facebook
pages will be further referred to as the “participant Facebook group pages”. Male and female
ESRD patients who were over the age of 18, receiving hemodialysis treatment, and were fluent
in English were included in this study. The study focused on the quality of life among ESRD
hemodialysis patients, therefore any patients undergoing peritoneal dialysis, transplantation, or
conservative management were excluded. Surveys from participants that did not meet the criteria
stated above or those that were incomplete were deleted and excluded from data analysis. We
anticipated responses from 100 participants.
Procedures
Description of research plan. The research collection took place from October 1, 2020
to January 2, 2021, during which time the research materials were available on the participant
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Facebook group pages. These materials, including the informed consent form, demographic
information, and the WHOQOL-BREF survey, were in the format of a single online survey
through the Qualtrics platform. The initial post to the “Living With Kidney Failure - End Stage
Renal Disease (ESRD) Support Group” Facebook page was made on October 1, 2020 and can be
found in Appendix B. Three additional Facebook groups were added to the study due to a limited
number of responses from participants (8 responses) in the “Living With Kidney Failure - End
Stage Renal Disease (ESRD) Support Group” Facebook group. Thus, the initial posts on the
“Hemodialysis Support Group”, “Dialysis and Kidney Disease Support Group”, and “Kidney
Dialysis Support Group” Facebook pages were made on October 23, 2020 (see Appendix C).
Following limited data collection from the four previously mentioned Facebook groups (21
responses), the researchers contacted the National Kidney Foundation (NKF) to request posting
the survey on the NKF Facebook page. After access was granted, the initial post to the NKF
Facebook page was made on December 10, 2020 (see Appendix D). Researchers were granted
permission to post on each of the participant Facebook group pages or were invited into the
private group pages by their respective administrators.
The Facebook posts contained a description of the research project, a statement of
consent, researcher contact information, and a link to the online survey (Appendix A).
Individuals who were members of the participant Facebook group pages at the time of data
collection could click on the link to the survey within the Facebook post and begin the survey. A
reminder post was posted to each participant Facebook group page to recruit more potential
participants halfway through the week. The follow-up posts for each Facebook group can be
found in Appendix E for “Living With Kidney Failure - End Stage Renal Disease (ESRD)
Support Group” Facebook page, Appendix F for the “Hemodialysis Support Group”, “Dialysis
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and Kidney Disease Support Group”, and “Kidney Dialysis Support Group” Facebook pages,
and Appendix G for the NKF Facebook page.
After clicking on the survey link, participants were electronically redirected to the online
survey on the Qualtrics platform. The survey began with a description of the study and the
informed consent form. Once participants acknowledged and agreed to the informed consent, the
demographic information questions appeared for participants to complete. If the participant
declined the informed consent, was not over 18 years of age, or was not a hemodialysis patient,
the survey automatically ended.
After the demographic questions were completed, participants automatically began the
WHOQOL-BREF portion of the survey. Participants were asked to answer every question,
however, were not required to submit an answer. The estimated time to complete the survey was
ten minutes. Upon completion of the survey, the online form was submitted to Qualtrics, which
brought about the “thank you” page and concluded participation (Appendix H). Completed
surveys were available solely to researchers as responses could only be accessed through the
password protected Qualtrics platform on secure computers owned by researchers. Any survey
responses that were incomplete, or those in which the participant did not meet inclusion criteria,
were removed from the number of total responses and data analysis.
Data analysis/statistics. Once the data was collected, the WHOQOL-BREF scoring
instructions were utilized to create formulas in Qualtrics that automatically assigned scores for
quality of life domains including total, environmental factors, physical health, psychological
health, and social relationships. Researchers elected to evaluate four of the six available domains
with the addition of a total overall score for the total of five quality of life scores (i.e., physical,
psychological, environment, and social). Researchers elected not to evaluate the independence
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and personal beliefs quality of life domains due to the limited number of questions. The data was
then downloaded onto Google Sheets to complete statistical analysis. Once on Google Sheets,
any responses that did not meet inclusion criteria were deleted from the data set. Survey
responses were then sorted based on comorbidity groups, age ranges, gender, time on treatment,
education level, and marital status.
The collected data was then organized into groups based on the presence or absence of
comorbid conditions (diabetes mellitus, obesity, diabetes mellitus and obesity, and neither
[referred to as the control group]) and was analyzed and compared using unpaired t-tests (i.e.,
control vs. diabetic; control vs. obese; control vs. diabetes and obesity; and diabetes vs. obesity).
Unpaired t-test values were used to determine if there was a statistical significance between
means in each domain (i.e., total, environmental, physical, psychological, and social) amongst
the comorbidity groups. Demographic information including age, gender, marital status, and
education level were also collected and analyzed with quality of life data to determine the
presence of any statistically significant relationships (see Appendix I). Unpaired t-tests were
used to evaluate age, gender, and marital status while ANOVA was used for evaluation of time
on treatment, education level, and for further analysis of marital status.
Disposition of data. After data collection ended, electronic survey data was compiled on
Qualtrics and subsequently downloaded into Google Sheets onto password-protected computers
owned by the researchers. Upon completion of analysis and presentation of results, the collected
data was transferred to an external storage device and data was erased from all computers. The
external drive will be locked in the PA program office for a minimum of five years, per
requirements of Bethel University’s Physician Assistant Program.
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Institutional Review Board (IRB) approval. This study was approved by Bethel
University’s Institutional Review Board (see Appendices J, K, L). The study sought level three
IRB approval. All appropriate materials were submitted to the Bethel University IRB committee
in September, 2020. The study was given level three IRB approval in September, 2020 (see
Appendix J). Following limited responses to the survey, researchers decided to increase the
participant pool by posting the survey to additional Facebook pages including the “Hemodialysis
Support Group”, “Dialysis and Kidney Disease Support Group”, and “Kidney Dialysis Support
Group” Facebook pages. An addendum was made to the original IRB application that was both
submitted to the IRB and approved in October 2020 (see Appendix K). Again, following limited
responses to the survey, researchers reached out to the National Kidney Foundation, from which
an administrator agreed to post the survey on the NKF Facebook page. One final addendum was
made to the IRB application in November 2020 to include the NKF Facebook page and was
subsequently approved in November 2020 (see Appendix L).
Data Collection
Informed consent. An informed consent form was the first page of the electronic
Qualtrics survey. The informed consent varied slightly between the participant Facebook group
pages. The “Living With Kidney Failure - End Stage Renal Disease (ESRD) Support Group”
Facebook group informed consent can be found in Appendix M and the “Hemodialysis Support
Group”, “Dialysis and Kidney Disease Support Group”, and “Kidney Dialysis Support Group”
Facebook pages informed consent can be found in Appendix N, and the NKF Facebook page
informed consent can be found in Appendix O.
The informed consent forms described the study, selection criteria, length of survey, and
information regarding data storage and how the data would be used. The consent forms stated
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that identifiable information, including name and date of birth, would not be collected or linked
to survey responses. The informed consents noted that participation in the study was voluntary,
participants could drop out of the study at any time, and participation in the study would not
impact their relationship with Bethel University or their respective participant Facebook group.
Contact information was provided to allow participants to contact the researchers regarding
questions about the study. If a participant chose to not accept the consent form, the Qualtrics
platform automatically ended the survey by bringing the participant to the “thank you” page (see
Appendix H).
Survey tool. An online WHOQOL-BREF survey was used as the data measurement tool
in this study (see Appendix A). A PDF version of the survey was available online with approval
from the University of Washington School of Public Health, Department of Health Services
Seattle Quality of Life Group. The approval for use of the WHOQOL-BREF survey is listed
under Appendix P. All instructions, questions, and scoring in the online survey were taken
directly from the PDF version of the survey. Demographic information was collected at the
beginning of the survey, including age, gender, marital status, country of residence, and
education level in an online format preceding the WHOQOL-BREF survey questions (see
Appendix I). Participants were also asked to report height, weight, and previous diagnosis of
diabetes mellitus.
In the WHOQOL-BREF survey, quantitative values from each quality of life domain
were rated on Likert scales ranging from 1 (not at all) to 5 (completely) (see Appendix A).
Participants were asked to reflect on experiences over the past two weeks of life to evaluate 26
items that pertained to six quality of life domains: physical health, psychological health,
independence, environmental factors, social relationships, and personal beliefs. Examples of
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questions included: “How would you rate your quality of life?”, “How satisfied are you with
your health?”, and “How often do you have negative feelings, such as blue mood, despair,
anxiety, depression?” (see Appendix A).
The survey tool contained a scoring system to calculate participant quality of life into the
six domains (i.e., physical, psychological, independence, environment, social relationships,
personal beliefs) (see Appendix Q) and researchers elected to evaluate four of the categories
(physical, psychological, environment, and social) in addition to total score as independence and
personal beliefs categories were evaluated by very few questions. First, for each domain, the raw
score was calculated by summing the items related to each domain, which included reverse
scoring three items. Second, the lowest possible raw score from each relative domain was
subtracted from each participant’s raw score for each domain, divided by the possible raw score
range, and multiplied by 100 to determine raw quality of life scores for each domain (i.e., the
transformed scale score) (see Appendix Q). The total quality of life score for each participant
was calculated by summing each domain raw score, subtracting the lowest possible raw score,
dividing by the possible total raw score range, and multiplying by 100 (see Appendix Q).
Validity and reliability of the survey. Participant quality of life was measured with a
voluntary questionnaire developed by the World Health Organization (WHO), known as the
WHOQOL-BREF. The WHOQOL-BREF measures quality of life with Likert scales and utilizes
a set formulary to interpret results (WHO, 2019; Bonomi, Patrick, Bushnell, & Martin, 2000).
While the WHOQOL-BREF was not specifically created for evaluation of quality of life in
ESRD patients, the questionnaire has been used in numerous studies to reliably determine ESRD
patient quality of life (e.g., Alhajim, 2017). Therefore, the WHOQOL-BREF was an appropriate
tool to measure quality of life in this study.
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Limitations and Delimitations
This study focused on participants with ESRD who were receiving hemodialysis
treatment at the time of data collection. In order to gather data from a wide variety of
participants, the study was conducted through ESRD support group pages on Facebook, a social
media platform. Additionally, participants were asked to reflect on their quality of life within the
last two weeks as they answered survey questions. The population, platform, and survey tool
were intentionally set in order to narrow the scope of the study and for consistency of results.
The collection of demographic information also served to identify potential confounding
variables that may impact quality of life of participants; specifically age, gender, country of
residence, marital status, and education level. While delimitations constrained the extent of the
study, limitations may have unintentionally impacted the results of this study.
Additional factors may have unintentionally interfered with the evaluation of quality of
life in the selected patient population. Limitations included potential participant response bias to
the WHOQOL-BREF and sampling bias as our population was obtained solely through an online
social media platform. Because the survey was administered online, participants may have
experienced unforeseen technical difficulties that potentially impacted their response to the
survey. Additionally, participants could have potentially submitted multiple responses to the
survey. The researchers further acknowledge that the COVID-19 pandemic may have impacted
the quality of life in participants which could be reflected in survey scores. In order to limit the
participant response bias to the WHOQOL-BREF, the methodology reflects that the participants
received no incentives for completing the questionnaire and participants were encouraged to
provide accurate information.
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Utilizing the WHOQOL-BREF survey tool ensured that questions were not written to
benefit or disbenefit groups within our population. The inclusion of only complete questionnaires
guaranteed that results are representative of the study population. Researchers also understand
that the participant population with access to the participant Facebook group pages may not be
an accurate representation of all ESRD patients receiving hemodialysis. Additionally, researchers
note that quality of life scores from participants within the support groups could be skewed
compared to quality of life scores from ESRD patients who were not in a support group at the
time of data collection.
Participant-reported height and weight were used to calculate BMI and measure obesity
among participants, however waist circumference is known to be a better indicator of abdominal
obesity and is more strongly associated with quality of life in ESRD patients (Beberashvili et al.,
2019). Although waist circumference is the best indicator, BMI was chosen as participants
readily know their height and weight. While limitations and delimitations of the study exist,
reasonable efforts were made to minimize their impact on the study.
Conclusion
In conclusion, this study examined whether a relationship exists between quality of life of
participants with ESRD receiving hemodialysis treatment and comorbidities of diabetes mellitus
and obesity by comparing mean quality of life scores. The study was conducted on Facebook, an
online social media platform, and was available to individuals with access to the participant
Facebook pages as defined previously. Participants completed an online informed consent,
demographic information, and WHOQOL-BREF survey that measured participant quality of life.
The scoring tool designed for the WHOQOL-BREF was used to ensure standardization of data.
Analysis of data included unpaired t-test and factorial analysis of variance (ANOVA).
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Organization of data and the results of the study are presented in Chapter Four. Chapter Five
includes a discussion of the results and impact of the study as well as ideas for the direction of
future research regarding ESRD and quality of life.
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Chapter Four: Data Analysis
Introduction
The intent of this study was to identify the presence and nature of the relationship
between quality of life and comorbidity groups (neither diabetes nor obesity [control group],
diabetes mellitus, obesity, or diabetes mellitus and obesity) among ESRD patients receiving
hemodialysis. There were a total of 363 online surveys collected through Facebook support
group pages. Data was collected and analyzed using Qualtrics and Google Sheets. There were
363 survey responses in total and 250 responses met exclusion criteria for participation and
further analysis. Participant quality of life was analyzed based on comorbidity groups as well as
demographic information to answer research questions and identify potential confounding
variables. Tables and figures were used to display the data collected in this study.
Demographics
At the completion of data collection, 363 responses were collected and downloaded from
Qualtrics to Google Sheets onto password protected, researcher owned computers. Of those
responses, 18 declined the informed consent, 86 did not meet participant inclusion criteria as
they were not receiving hemodialysis treatment, eight survey takers did not report a BMI, and
one was discarded as an outlier because the BMI was outside of the possible range of BMI
values. Thus, the final population of this study that met the inclusion criteria was 250
participants. The demographic information from the 250 surveys was analyzed using Google
Sheets. Table 3 presents a breakdown of the total survey responses and number of surveys in
each exclusion category as well as the final number of surveys included in the study’s data
analysis. The “n” represents the number of participants in all following tables.
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Table 3.
Survey response breakdown describing number of surveys excluded for which criteria.
Survey Responses

n

Total Surveys

363

Declined Informed Consent

18

Participant not on Hemodialysis

86

Participant Did Not Answer BMI

8

Participant BMI Out of Range

1

Surveys Meeting Inclusion Criteria

250

Of the 250 participants, 126 were male and 124 were female, zero identified as “other”
(see Table 4).
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Table 4.
Part 1: Demographic information of participants; gender.
Demographic Variable

Total Participants

Percentage of Total

Gender

n

%

Male

126

50.4

Female

124

49.6

Other

0

0.0

For age, participants were grouped by ranges of approximately 10 years (see Table 5).
After initial grouping revealed ranges with small sampling sizes, participants were regrouped
into two larger, more equal populations for analysis. Of the 105 participants in the 20 to 59 year
age group, 44 were male and 61 were female. The 145 participants in the 60 years and older
group consisted of 82 males and 63 females.
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Table 5.
Part 2: Demographic information of participants; age.
Demographic Variable

Total Participants

Percentage of Total

Age Range (years)

n

%

20-29

8

3.2

30-39

16

6.4

40-49

27

10.8

50-59

54

21.6

60-69

81

32.4

70-79

50

20.0

Over 80

14

5.6

Final Age Range (years)

n

%

20-59

105

42.0

Over 60

145

58.0

Of the 250 eligible responses, 69 participants had been receiving hemodialysis for six
months to two years, 83 participants for two to five years, and 98 participants for five or more
years. Initial treatment categories were broken down into equal time frames, however with
variable population sizes in each category, the decision was made to reduce categories to those
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shown below in Table 6. There were no participants included in the study with a treatment time
less than six months. Because of this, researchers are confident there are no participants within
the study receiving hemodialysis for an acute kidney injury and are all receiving treatment for
chronic kidney disease in this study.
Table 6.
Part 3: Demographic information of participants; time on treatment.
Demographic Variable

Total Participants

Percentage of Total

Time on Treatment (years)

n

%

0-2

69

27.6

2-5

83

33.2

Over 5

98

39.2

Initial marital status groupings revealed over half of participants were married. In order to
stabilize sample sizes, groups were reduced to married and unmarried. Unmarried category
including single, divorced, separated, or widowed. Married including those married and those
living as married. Data analysis for marital status is done with the acknowledgement that the
unmarried category includes subcategories for which there may exist differences that influence
quality of life scores. Total participants and percentage of total population for marital status
categories are presented below in Table 7.
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Table 7.
Part 4: Demographic information of participants; marital status.
Demographic Variable

Total Participants

Percentage of Total

Marital Status

n

%

Divorced or Separated

31

12.4

Married or Living as Married

133

53.2

Single

64

25.6

Widowed

22

8.8

Final Marital Status

n

%

Unmarried

117

46.8

Married

133

53.2

Grouping for education level was similar to that of marital status and age group (see
Table 8). In order to create comparable groups with similar sample sizes, the “elementary” and
“some high school” subgroups were combined with the “high school/GED” group. Final groups
revealed 81 participants with high school or less education, 63 with an associates degree, and
106 with bachelors/masters/PhD.
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Table 8.
Part 5: Demographic information of participants; education level.
Demographic Variable

Total Participants

Percentage of Total

Education Level

n

%

Elementary

1

0.4

Some High School

1

0.4

High School / GED

79

31.6

Associates

63

25.2

Bachelors/Masters/PhD

106

42.4

Final Education Level

n

%

High School or Less

81

32.4

Associates

63

25.2

Bachelors, Masters, PhD

106

42.4

Within the population of 250 participants, there were 99 participants who had neither
diabetes or obesity (control group), 36 participants with diabetes only, 59 participants with
obesity only, and 56 participants with both diabetes and obesity. Table 9 below shows this
numerically with percentages of the comorbidity groups corresponding to the total population.
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Table 9.
Part 6: Demographic information of participants; comorbidity group.
Demographic Variable

Total Participants

Percentage of Total

Comorbidity Group

n

%

None

99

39.6

Diabetes

36

14.4

Obesity

59

23.6

Diabetes and Obesity

56

22.4

Table 3 through Table 9 above describe the population of the study in detail with the total
number of participants in each category and the percentage of total population each category
represents. The primary focus of this study, however, is to analyze the quality of life of each of
the comorbidity groups listed in Table 6. The following section discusses the process of data
analysis and leads into display of results.
Data Analysis
Quality of life scores were analyzed using the scoring algorithm provided by the
WHOQOL-BREF. Appendix Q outlines the guidelines used to score all eligible survey
responses. Within the survey platform, Qualtrics, scores were automatically calculated for each
participant in the domains of total quality of life, physical health, psychological health,
environmental factors, and social relationships. Demographic information, excluding any
specific participant identifiers, as well as raw data, and calculated domain scores were
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downloaded onto Google Sheets. Google Sheets was then used to calculate the results between
quality of life among comorbidity groups with unpaired t-tests. In addition to analyzing quality
of life scores in each comorbidity group, unpaired t-tests and ANOVA statistical testing were
performed to analyze quality of life scores for each demographic category. The remainder of this
section is dedicated to a display of results for both the research questions and demographic
analysis.
Research questions. As stated previously, the goal of the study was to evaluate the
relationship between quality of life and comorbid conditions, diabetes and obesity, in the setting
of end-stage renal disease. In order to answer research questions, analysis was done examining
the mean quality of life scores in each of the groups across all five domains (i.e., total, physical
health, psychological health, environmental factors, and social relationships). The mean total
quality of life score of the control group was 64.3 (SD = 16.4), the diabetes group was 53.8 (SD
= 18.9), the obesity group was 59.1 (SD = 13.9), and the diabetes and obesity group was 57.8
(SD = 15.7). The quality of life domains (i.e., environmental, physical, psychological, social)
were also analyzed for each comorbidity group as shown in Table 10 through Table 14 below.
Scores have all been transformed into percentages by the WHOQOL-BREF survey scoring
instructions. Scores closer to 100 are consistent with higher quality of life while lower scores or
those closer to zero, reflect poorer quality of life.
Table 10 provides an overview of mean quality of life scores for each comorbidity group
across all domains of quality of life. In sum, this table depicts that the control group reported
higher quality of life scores across all domains when compared to the other comorbidity groups.
In contrast, the diabetes group reported the lowest quality of life scores across all quality of life
domains when compared to the other comorbidity groups including participants with both
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diabetes and obesity. Another notable trend from the data analysis is that the environmental
factors domain has higher quality of life scores than all other domains within each comorbidity
group. The lowest quality of life scores are found in the physical health domain.
Table 10.
Presentation of mean quality of life scores between comorbid groups.
Comorbidity

n

Control

Total

Environmental Physical

Psychological Social

99 64.3 ± 16.4

74.9 ± 16.3

57.5 ± 19.9

62.7 ± 19.7

58.2 ± 22.4

Diabetes

36 53.8 ± 18.9

62.5 ± 19.2

46.2 ± 20.1

53.0 ± 22.8

52.1 ± 21.5

Obesity

59 59.1 ± 13.9

67.6 ± 14.0

51.3 ± 19.1

59.7 ± 16.5

55.8 ± 21.3

Diabetes & Obesity 56 57.8 ± 15.7

67.4 ± 17.3

49.0 ± 17.8

60.3 ± 19.1

51.2 ± 22.7

Tables 11 through 14 illustrate the statistical difference between each of the comorbidity
groups presented individually as compared to the control group. P values less than or equal to
0.05 are considered statistically significant while any p values greater than 0.05 are not
statistically significant. Additionally, p values less than 0.01 are considered highly significant.
For simplicity, any statistically significant p values are denoted as <0.05* or <0.01** to highlight
significance. Any p values that are not significant are shown as their calculated value.
Table 11 starts with comparing the mean quality of life scores of the control group to the
diabetes group. This analysis aims to answer research question one; “what relationship, if any,
exists between diabetes mellitus and quality of life in ESRD patients receiving hemodialysis
treatment?”. Unpaired t-tests were used to analyze the statistical difference between the mean
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scores of each of the domains. Analysis revealed statistically significant differences (p values
≤0.05) in mean scores between the diabetes and control groups in total, environmental, physical,
psychological domains. The diabetes group was shown to have lower quality of life scores in
these domains when compared to the control group. Social relationships is the only
non-significant domain with a p value of 0.16. Despite lack of statistical significance, the
diabetes group continued to have lower quality of life scores in the social relationships domain as
well, when compared to the control group. Domains for the diabetes group listed from highest
score to lowest score are as follows; environmental factors, total score, psychological health,
social relationships, and physical health.
Table 11.
Analysis of mean quality of life scores; Diabetes Group versus Control Group.
Comorbidity

n

Total

Environmental

Physical

Psychological

Social

Control

99

64.3 ± 16.4

74.9 ± 16.3

57.5 ± 19.9

62.7 ± 19.7

58.2 ± 22.4

Diabetes

36

53.8 ± 18.9

62.5 ± 19.2

46.2 ± 20.1

53.0 ± 22.8

52.1 ± 21.5

<0.05*

<0.05*

<0.05*

<0.05*

0.16

p value

In order to answer the second research question; “what relationship, if any, exists
between obesity and quality of life in ESRD patients receiving hemodialysis treatment”, an
analysis of means between the control group and obesity group was done using unpaired t-tests.
Analysis revealed statistically significant differences in the total quality of life and the
environmental factors domain with the obesity group having poorer quality of life scores than the
control group. Physical health, psychological health, and social relationships domains had p
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values greater than 0.05 and therefore were not statistically significant, however the trend of
lower quality of life scores in the obesity group continued. In both the control group and the
obesity group, physical health had the lowest quality of life score out of all the domains with
57.5 ± 19.9 and 51.3 ± 19.1 respectively. On the other hand, both groups had the highest quality
of life scores in the total category, followed by, in order from highest to lowest, environmental
factors, psychological health, and social relationships.
Table 12.
Analysis of mean quality of life scores; Obesity Group versus Control Group.
Comorbidity

n

Total

Environmental

Physical

Psychological

Social

Control

99

64.3 ± 16.4

74.9 ± 16.3

57.5 ± 19.9

62.7 ± 19.7

58.2 ± 22.4

Obesity

59

59.1 ± 13.9

67.6 ± 14.0

51.3 ± 19.1

59.7 ± 16.5

55.8 ± 21.3

<0.05*

<0.05*

0.06

0.31

0.51

p value

The previous two tables, Table 11 and Table 12, portray mean quality of life scores for a
single comorbidity, either diabetes or obesity, compared to that of the control group intending to
answer the first two research questions. The following table, Table 13, presents the analysis of
mean scores between the participants with both diabetes and obesity and participants with neither
comorbid condition. This analysis is an addition to the original research questions and aims to
gain understanding of how participant quality of life scores are affected by the presence of both
comorbid conditions.
Again, the two groups were analyzed using unpaired t-tests to determine corresponding p
values and thus presence of statistical significance. In doing so, three domains of quality of life
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were found to be significantly different. Total quality of life was significantly reduced in the
diabetes and obesity group (57.8 ± 15.7) when compared to the control group (64.3 ± 16.4). The
environmental factors and physical health domains were found to be highly significant with the
diabetes and obesity group having poorer quality of life scores than the control group.
Psychological health was not statistically significant between the two groups. Social
relationships, though potentially more significant than psychological health, was also found to be
not significant with a p value of 0.07. The analysis of the diabetes and obesity group versus the
control group followed a similar trend to those before with the highest quality of life score being
environmental factors, followed by psychological health, social relationships, and, finally
physical health.
Table 13.
Analysis of mean quality of life scores; Diabetes and Obesity Group versus Control Group.
Comorbidity

n

Total

Environmental Physical

Psychological Social

Control

99

64.3 ± 16.4

74.9 ± 16.3

57.5 ± 19.9 62.7 ± 19.7

58.2 ± 22.4

Diabetes & Obesity 56

57.8 ± 15.7

67.4 ± 17.3

49.0 ± 17.8 60.3 ± 19.1

51.2 ± 22.7

p value

<0.05*

<0.01*

<0.01*

0.07

0.46

Research question three; “Which comorbidity, diabetes mellitus or obesity, is more
strongly related to a decreased quality of life among ESRD patients who are receiving
hemodialysis?”, was addressed in the same way as the previous two questions. Unpaired t-tests
were used to compare mean quality of life scores between the diabetes group and the obesity
group. Despite the diabetes group having lower quality of life scores in every domain, this
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analysis revealed no statistical difference between the two comorbidity groups. There were no p
values less than 0.05 or even below 0.10. The greatest difference between the two groups was
found in the psychological domain with the diabetes group scoring 53.0 ± 22.8 and the obesity
group 59.7 ± 16.5. The same general trend held true for this analysis with environmental quality
of life the highest scoring domain with physical health the lowest.
Table 14.
Analysis of mean quality of life scores; Diabetes Group versus Obesity Group.
Comorbidity

n

Total

Environmental

Physical

Psychological

Social

Diabetes

36

53.8 ± 18.9

62.5 ± 19.2

46.2 ± 20.1

53.0 ± 22.8

52.1 ± 21.5

Obesity

59

59.1 ± 13.9

67.6 ± 14.0

51.3 ± 19.1

59.7 ± 16.5

55.8 ± 21.3

0.15

0.17

0.23

0.13

0.42

p value

Analysis of quality of life scores between the control group, diabetes group, obesity
group, and diabetes and obesity group revealed multiple statistically significant differences and
trends. Environmental factors quality of life scores were the highest scores for each group while
physical health consistently had the lowest quality of life scores. Of all of the comorbidity
groups, the diabetes mellitus group had the lowest scores in all domains of quality of life,
statistically significant in total, physical health, psychological health, and environmental factor
domains. The obesity group was found to have lower quality of life scores than the control
group, however, higher than the diabetes group and only statistically significant in the total and
environmental factors domains. The diabetes and obesity group also had lower quality of life
scores in all domains compared to the control group, with statistically significant differences in
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the total, environmental factors, and physical health domains. Finally, when comparing diabetes
and obesity to one another, no statistically significant differences were found. General trend,
however, revealed lower quality of life scores in the diabetes group across all domains when
compared to the obesity group.
While the statistical analysis across comorbidity groups shows significant differences in
quality of life scores, there may be additional confounding factors to consider. The following
section is dedicated to analyzing specific demographics of the study population in order to
identify any potentially significant relationships between age, gender, time on treatment,
education level, marital status, and quality of life scores. Data in this section is presented in a
similar format to that of this section and similar analyses with unpaired t-tests and ANOVA are
displayed for interpretation in Chapter Five.
Demographic analysis. As stated in previous sections, analysis was also performed on
demographic information gathered as part of the quality of life questionnaire. Particular areas of
interest include age, gender, time on treatment, education level, and marital status. Researchers
chose not to analyze participant country of residence as there was insufficient information
provided through survey responses. Tables 15 through 19 display the mean quality of life scores
across all domains for each demographic category. Analysis included unpaired t-tests for
analyses with two groups and ANOVA for analyses with three or more groups.
For examination of the quality of life scores between the two, larger age groups, 20 to 59
years old and 60 years and older, unpaired t-tests were used to calculate statistical significance.
Table 15 displays mean scores for each domain across the two age groups. Mean quality of life
scores were significantly higher in the 60 and older age group when compared to the 20 to 59
year age group. The highest quality of life score was found in the environmental factors domain
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for both age groups and the lowest scores were again found in the physical health domain.
Highly statistical differences between the two groups were present in the total, environmental
factors, and psychological health domains with p values less than or equal to 0.01. The physical
health and social relationships domains did not have statistically significant differences in mean
quality of life scores.
Table 15.
Analysis of mean quality of life scores; age in years.
Age

n

Total

Environmental

Physical

Psychological

Social

20-59

105

56.6 ± 17.0

64.4 ± 18.0

50.7 ± 18.8

55.6 ± 20.2

52.6 ± 24.6

60+

145

62.6 ± 21.3

73.5 ± 15.2

53.8 ± 20.2

63.2 ± 18.4

57.0 ± 20.0

<0.01*

<0.001**

0.22

<0.01*

0.13

p value

Similar to the analysis of age above, Table 16 illustrates the mean quality of life scores
across gender. Participants had the option to select “male”, “female”, or “other” for gender and
approximately fifty percent were male and fifty percent were female. No participants identified
as “other”. The only statistically significant difference in means between males and females was
found in the social relationships domain with the p value less than 0.05. Despite there being no
other statistically significant domains, females tended to have lower quality of life scores than
males within the study in every domain except social relationships.

66
Table 16.
Analysis of mean quality of life scores; gender.
Gender

n

Total

Environmental

Physical

Psychological

Social

Female

124

59.5 ± 15.9

68.5 ± 16.7

51.6 ± 19.0

58.5 ± 18.9

58.5 ± 20.9

Male

126

60.6 ± 16.9

70.9 ± 17.2

53.5 ± 20.2

61.5 ± 20.0

51.9 ± 23.0

0.60

0.25

0.45

0.22

<0.05*

p value

The first demographic category to be analyzed using ANOVA is shown in Table 17.
Participants were grouped based on years receiving hemodialysis treatment. Of note, no
participants were on hemodialysis for less than six months ensuring only chronic kidney disease
patients are included in the study. Statistical analysis revealed no significant differences in
quality of life scores between participants receiving hemodialysis for zero to two years, two to
five years, and five or more years. General trends revealed that those on hemodialysis for shorter
periods of time had higher quality of life scores while those on hemodialysis for more than five
years had the lowest overall quality of life scores.
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Table 17.
Analysis of mean quality of life scores; time on treatment in years.
Treatment Time

n

Total

0-2

69

2-5
5+
p value

Environmental

Physical

Psychological

Social

62.4 ± 13.8 72.1 ± 16.1

53.8 ± 17.4

62.7 ± 15.5

58.9 ± 19.9

83

59.0 ± 16.4 69.2 ± 15.8

53.3 ± 20.6

57.4 ± 20.1

52.1 ± 22.2

98

59.3 ± 18.0 68.5 ± 18.5

51.0 ± 20.4

60.4 ± 21.3

55.1 ± 23.4

0.37

0.60

0.24

0.17

0.38

Perhaps the most significant demographic category for this study was education level.
Participants were grouped based on education level, high school/GED/less education, associates
degree, or bachelors/masters/PhD. There were only two participants with less than a high school
diploma, one with elementary education and one with only some high school education.
Participants with a bachelors/masters/PhD had higher quality of life scores than those with less
education. Those with an associates degree tended to have lower quality of life scores than those
with high school or less. Every domain of quality of life, including total score, had statistically
significant differences in quality of life scores. Most notably, total quality of life and
environmental factors had very highly significant differences with p values less than 0.001.
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Table 18.
Analysis of mean quality of life scores; education level. High school or less, associates degree,
bachelors/masters/PhD.
Education

n

Total

≤ High School

81

Associates
≥ Bachelors
p value

Environmental

Physical

Psychological

Social

57.1 ± 15.4 66.6 ± 17.0

49.5 ± 17.2

56.3 ± 18.0

52.9 ± 21.6

63

55.8 ± 17.5 64.1 ± 16.9

50.2 ± 19.5

56.3 ± 20.9

49.2 ± 25.2

106

64.9 ± 15.3 75.4 ± 15.4

56.2 ± 21.0

65.1 ± 18.8

60.5 ± 19.5

<0.001**

<0.05*

<0.05*

<0.05*

<0.001**

The last demographic category analyzed was marital status. Participants were grouped
into two larger groups of married (including living as married) or unmarried (including single,
divorced, separated, and widowed) to create comparable sample sizes. General trend indicates
married participants had higher quality of life scores in all domains when compared to unmarried
participants. Unpaired t-tests were used and statistically significant differences were found in all
domains except social relationships. The greatest difference was found in the environmental
factors domain, married (72.7 ± 15.9) and unmarried (57.5 ± 17.3) groups with a p value of less
than 0.01. Table 19 below portrays the mean quality of life scores for each domain as related to
marital status.
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Table 19.
Analysis of mean quality of life scores; marital status.
Marital Status n

Total

Environmental

Physical

Psychological

Social

Married

133

62.4 ± 15.3

72.7 ± 15.9

54.9 ± 18.6

62.4 ± 18.6

56.0 ± 20.7

Unmarried

117

57.5 ± 17.3

66.4 ± 17.6

49.8 ± 20.5

57.4 ± 20.3

54.3 ± 23.8

<0.05*

<0.01*

<0.05*

<0.05*

0.55

p value

Analysis of the demographic categories of age, gender, time on treatment, education
level, and marital status revealed multiple statistically significant findings. The mean quality of
life scores were significantly different between younger participants and older participants with
higher scores found in those over 60 years of age in total, environmental factors, and
psychological health domains. Neither gender nor time on treatment had any significant
differences in mean quality of life scores while education level and marital status had statistically
significant differences in all or almost all domains. In general, the quality of life scores within
the demographic categories followed similar trends as previous analysis of comorbidity groups
with environmental factors having had the highest scores and physical health having had the
lowest.
Conclusion
The analysis of participant quality of life within demographic categories and comorbidity
groups was presented throughout Chapter Four. Exclusively through the use of tables,
comparisons between comorbidity groups and demographic categories were made by presenting
mean quality of life scores and corresponding p values. P values less than or equal to 0.05 were
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considered significant while p values greater than 0.05 were not significant. This conclusion will
serve as a summary of the data analysis highlighting general trends and significant findings.
At the end of data collection, there were 250 eligible participants that met all of the
inclusion criteria for the study. Of those 250 participants, 99 participants had neither diabetes nor
obesity (control group), 36 participants had only diabetes, 59 participants had only obesity, and
56 participants had both diabetes and obesity. Through use of unpaired t-tests, statistically
significant differences in mean quality of life scores were found between diabetes and control
group participants, obesity and control group participants, and both diabetes and obesity and the
control group. No statistically significant difference was found between the diabetes and obesity
groups. In each of these comparisons, the comorbidity groups scored lower on quality of life
measures than the control group. The diabetes group had the lowest overall quality of life scores
across each domain in comparison to all other comorbidity groups, even the diabetes and obesity
group. Analysis of these groups also revealed that the environmental factors domain had the
highest quality of life scores across all comorbidity groups while physical health had the lowest
scores in each group. While analysis of the comorbidity groups was the primary focus of this
study, additional analysis of demographic categories was done to identify any significant
confounding variables that may have influenced scoring trends.
For demographic analysis, unpaired t-tests were used to make comparisons within the
age, gender, and marital status categories. ANOVA was used in the analysis of time on treatment
and education level categories. The same p value cutoffs were used for determination of
significance within these analyses (i.e., p value less than or equal to 0.05 is significant, p value
greater than 0.05 is not significant). Analysis revealed statistical significance within the age,
education level, and marital status categories. Participants older than 60 years of age generally
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had higher quality of life scores than those younger than 60. Participants with a bachelors,
masters, or PhD had higher quality of life scores than those with an associates, high school or
less education. And finally, married participants had higher quality of life scores than unmarried
participants. General trends also revealed that environmental factors had the highest scores while
physical health had the lowest. This trend is consistent with the trends found in the comorbidity
groups analysis.
Data analysis yielded multiple statistically significant differences in mean quality of life
scores, both within the comorbidity groups and within the demographic categories of age,
education level, and marital status. The fifth and final chapter of this study further discusses the
results of data analysis, tying results to previous research, and presents potential reasons for the
differences found in participant quality of life. Additionally, the chapter evaluates possible areas
for further research and, again, explores limitations of this study.
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Chapter Five: Discussion
Introduction
The purpose of this study was to evaluate whether a relationship exists between quality of
life in ESRD patients receiving hemodialysis treatment and diabetes and obesity. The researchers
in this study also examined which comorbidity, diabetes or obesity, was more significantly
related to quality of life in the patient population. Specifically, the study focused on comparison
of quality of life scores between the control group (neither diabetes or obesity) and diabetes,
obesity, and both diabetes and obesity groups. Additional analysis of demographic information
including age, gender, time on treatment, education level, and marital status was done to identify
significant relationships and potential confounding variables within the study design. This
chapter discusses the results of the study and includes a description of the limitations, direction
for future research, and a conclusion of this research study. Discussion of results are divided
based on research questions addressed and quality of life domain.
Results Related to Research Questions
When analyzing the relationship between diabetes and quality of life, this study showed
that the presence of diabetes in ESRD patients receiving hemodialysis was associated with lower
quality of life when compared to participants without diabetes. Participants with diabetes
reported a statistically significant lower quality of life score in four of the five quality of life
domains with the exception being the social relationships category as discussed in the “Social
Relationship” section below.
When considering the relationship between obesity and quality of life, this study showed
that participants with obesity also had lower quality of life scores when compared to the control
group. Of note, the decreased quality of life scores that resulted from the obesity group were only
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statistically significant in the total and environmental domains when compared to the control
group.
When analyzing whether the comorbidity of diabetes or obesity is more strongly related
to a decreased quality of life, there was no statistically significant evidence to conclude which
comorbidity is more strongly related to a decreased quality of life. Despite there being no
statistical difference, when directly comparing diabetes to obesity, participants with diabetes
reported lower quality of life scores across all five of the domains when compared to participants
with obesity. Furthermore, the presence of both comorbidities did not equate to lower quality of
life scores when compared to diabetes or obesity alone. In fact, participants with diabetes alone
had lower quality of life scores than participants with both diabetes and obesity. A detailed
discussion of each quality of life domain will be discussed in the next section, “Results Related
to Quality of Life Domain”.
Results Related to Quality of Life Domain
Total quality of life. In this study, the control group reported the highest quality of life
scores across all domains when compared to other comorbidity groups. The difference in total
quality of life was statistically significant between the control group and the diabetes group, with
quality of life scores being significantly higher in the control group (64.3 ± 16.4, 53.8 ± 18.9;
p<0.05). These findings are consistent with studies that were previously discussed in Chapter
Two. Most notably, one study showed that patients with diabetes mellitus and kidney disease
who were not yet receiving hemodialysis had a lower quality of life than patients already
receiving hemodialysis who did not have diabetes (Zimbudzi et al., 2016). Participants with
diabetes may have rated their overall quality of life and satisfaction with their overall health
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lower than the control group because diabetes may negatively impact things like functional
status, work capacity, and financial resources due to the burden of the disease.
When considering obesity, total quality of life was significantly higher in the control
group compared to the obesity group (64.3 ± 16.4, 59.1 ± 13.9; p<0.05). This is also consistent
with the previous literature discussed in Chapter Two. For example, Turgut and Abdel-Rahman
(2017) and Beberashvili et al. (2019) found that obese ESRD patients receiving hemodialysis had
lower quality of life than non-obese ESRD patients. Additionally, Knudsen, Eidemak, and
Molsted (2016), who examined two groups of ESRD patients 13 years apart, found that the later
group had a higher BMI and lower quality of life than the earlier group.
In this study, participants with obesity may have rated their overall quality of life and
satisfaction with their health lower than non-obese participants for many reasons. For example,
higher incidence of hemodialysis treatment complications, limited functional status, and higher
incidence of depression in obese individuals are a few of many factors that may play a role. A
longitudinal meta-analysis done in 2010 (Luppino, et al.) revealed that those with obesity had a
55% higher risk of developing depression in their lifetime when compared to those without
obesity, likely contributing to poorer quality of life overall.
Additionally, total quality of life was statistically significant between the control group
and the diabetes and obesity group, with total quality of life scores significantly higher in the
control group (64.3 ± 16.4, 57.8 ± 15.7; p<0.05). Relatedly, previous literature has shown that
multiple comorbidities, including both diabetes and obesity, negatively impact quality of life in
kidney disease patients (Liu, Yeh, Weng, Bai, & Chang, 2017; Mandoorah, Shaheen, Mandoorah,
Bawazir, & Alshohaib, 2014). This finding may be because the factors that negatively impact
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individuals with either diabetes or obesity confound to decrease overall quality of life in the
diabetes plus obesity group.
Environmental factors. Environmental quality of life takes into account concepts such
as a healthy physical environment, financial resources to meet basic needs, resources and
availability for leisure activities, living space conditions, and access to health services and
transportation. Environmental quality of life was found to be significantly lower in the diabetes
group when compared to the control group (62.5 ± 19.2, 74.9 ± 16.3; p<0.05). Extensive
management and complications associated with the presence of diabetes including retinopathy,
neuropathy, medications, and blood sugar management could play a role in difficulties with
finances, health services, and transportation which could contribute to lower quality of life
scores.
The obesity group also had a significantly lower quality of life regarding environmental
factors than the control group (67.6 ± 14.0, 74.9 ± 16.3; p<0.05). A systematic review found that
morbidly obese ESRD patients receiving hemodialysis have a lower quality of life than
non-obese patients due to factors including more frequent dialysis visits, difficulty with
transportation, and inability to maneuver clinic spaces (Turgut & Abdel-Rahman, 2017). The
aforementioned factors could contribute to the lower environmental quality of life scores.
Similar to the trends regarding the presence of diabetes or obesity, the presence of both
diabetes and obesity was associated with poorer quality of life scores when compared to the
control group (74.9 ± 16.3, 67.4 ± 17.3, p<0.01). The factors that may have contributed to
decreased quality of life with each comorbidity alone could remain true and, in combination,
may be further amplified given the increased disease burden of both comorbidities.
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Physical health. Physical quality of life takes into account the impact of disease on
activities, energy level, dependency on medical treatment as a means to function, functional
status, sleep, ability to perform activities of daily living, and the capacity to work. Similar to
previous trends, when analyzing the presence of diabetes, physical quality of life was
significantly lower in the diabetes group when compared to the control group (46.2 ± 20.1, 57.5
± 19.9; p<0.05).
As previously mentioned, diabetes can lead to various complications, each may lead to
impairment of physical health. Examples of this include retinopathy, which may cause visual
impairment; peripheral vascular disease, which may lead to claudication or amputation; or
neuropathy, which may cause chronic pain (Inzucchi & Lupsa, 2020). Such physical impairments
may limit or inhibit individuals from performing daily living activities, work requirements, or
activities that promote higher quality of life (e.g., participating in family activities) (Inzucchi &
Lupsa, 2020). Another notable component of physical quality of life in those with diabetes is that
these individuals are likely dependent on anti-diabetic medications. These medications come
with several side effects, such as hypoglycemia and weight gain that may also negatively impact
quality of life (Inzucchi & Lupsa, 2020). Additionally, the potential need for injectable
medications such as insulin, and fingerstick glucose checking adds physical discomfort and
inconvenience to the list of factors that may decrease quality of life of diabetic participants.
There was no significant difference in physical quality of life between the control group
and the obesity group (57.5 ± 19.9, 51.3 ± 19.1; p=0.06). Previous research has shown an
increased incidence of chronic pain in individuals with obesity, as discussed in a systematic
review by (Okifuji & Hare, 2015). Additionally, there is a higher incidence of functional
impairment in obese individuals compared to non-obese individuals, potentially leading to
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decreased quality of life (Jenkins, 2004). Less severe obesity may not cause as significant
functional impairment, limitations of daily activities, or decreased work capacity. Further
division of BMI categories may be beneficial in drawing additional conclusions regarding the
relationship between quality of life and obesity.
When comparing the diabetes and obesity group with the control group, the diabetes and
obesity group reported a statistically significant lower quality of life score when compared to the
control group (57.5 ± 19.9, 49.0 ± 17.8, p<0.01). This finding may be due to a combination of
the factors that contribute to decreased physical quality of life in the diabetes group and the
obesity group described above.
Psychological health. Psychological quality of life takes into account enjoyment of life,
ability to view life as meaningful, ability to concentrate, accepting bodily appearance,
satisfaction with self, and the presence of negative feelings. There was a significant difference in
psychological quality of life between the control group and the diabetes group, with higher
psychological health in the control group (62.7 ± 19.7, 53.0 ± 22.8; p<0.05). Previous literature
suggests that diabetes is associated with depression, negatively impacting psychological health
(Bădescu et al., 2016). This associated depression could lead to the presence of negative feelings,
dissatisfaction with self, and decreased enjoyment of life.
Psychological quality of life was not significantly different between the control and
obesity groups (62.7 ± 19.7, 59.7 ± 16.5; p=0.31). Additionally, there was also no significant
difference in psychological quality of life between the control group and the diabetes and obesity
group (62.7 ± 19.7, 60.3 ± 19.1; p=0.46). Despite previous studies showing an increased risk of
depression in those with obesity, participants of this study did not portray significant differences
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in questions regarding satisfaction with self, enjoyment of life, ability to concentrate, or ability to
view life as meaningful.
Social relationships. Social quality of life takes into account satisfaction with personal
relationships, sex life, and support from friends. Social quality of life between the diabetes group
and the control group (52.1 ± 21.5, 58.2 ± 22.4; p=0.16), control group and obesity group (58.2 ±
22.4, 55.8 ± 21.3; p=0.51), control group and diabetes and obesity group (58.2 ± 22.4, 51.2 ±
22.7; p=0.07), and the diabetes group and the obesity group (52.1 ± 21.5, 55.8 ± 21.3; p=0.42)
revealed no statistical differences. The social quality of life may not have been significantly
different in these groups given that the participants were all members of at least one support
group, which may have positively influenced their social relationships by providing social
support and access to personal relationships.
Demographic Findings
In addition to evaluation of the research questions using the WHOQOL-BREF,
researchers evaluated demographic information including age, gender, time on treatment, marital
status, and education level. The purpose of these analyses was to highlight areas of significant
relationships between participant demographics and quality of life. The following discussion is
divided by demographic category and is presented as supplemental to the above findings related
to the research questions. While these findings are significant, they are not the primary focus of
the study and are thus discussed briefly. Further investigation into these topics may yield more
definitive conclusions.
Age and quality of life. There was a significant difference in the quality of life with
individuals over the age of 60 reporting increased scores in total quality of life (56.6 ± 17.0, 62.6
± 21.3, p<0.01), environmental factors (64.4 ± 18.0, 73.5 ± 15.2, p<0.001), and psychological
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health (55.6 ± 20.2, 63.2 ± 18.4, p<0.01) when compared to individuals 59 years of age or
younger. Researchers predict that participants over the age of 60 may have higher quality of life
scores due to improved satisfaction with self, ability to view life as meaningful, increased access
to transportation, and increased stability of financial resources. Given the significance found in
this category, further research may be beneficial in identifying potentially contributing factors.
Gender and quality of life. There was no significant difference in overall quality of life
between male and female participants. Of note, there was a significant difference in social
quality of life scores with females reporting an overall higher social quality of life score when
compared to males (58.5 ± 20.9, 51.9 ± 23.0, p<0.05). This may indicate that female participants
have a stronger social network for support than their male counterparts. Women may feel more
inclined to accept help and comfort from their friends and family than men which may relate to
higher social scores for women.
Time on treatment and quality of life. There was no significant difference in quality of
life when comparing the number of years receiving hemodialysis treatment. The insignificance in
this section may be, like all other sections, multifactorial. Those on treatment for longer periods
of time may feel more established in their treatment routine and may have reached a point of
acceptance allowing them to find a new “normal” way of living. The reverse may be true of
those on treatment for less time: they may have more uncertainty about their disease and the
treatment course or may feel overwhelmed by the burden of disease. In this population, quality
of life scores were not significantly different across length of treatment times.
Marital status and quality of life. There was statistical significance in overall (62.4 ±
15.3, 57.5 ± 17.3, p<0.05), environmental (72.7 ± 15.9, 66.4 ± 17.6, p<0.01), physical (54.9 ±
18.6, 49.8 ± 20.5, p<0.5), and psychological (62.4 ± 18.6, 57.4 ± 20.3, p<0.05) quality of life
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with individuals who are married reporting an increase in quality of life scores when compared
to individuals who are unmarried. The unmarried group in this study consists of those that are
single, separated, divorced, and widowed. With the presence of a spouse, it is possible that
qualities such as finding meaning in one’s life, having readily available assistance with activities
of daily living and transportation, and a decrease in personal financial strain decrease disease
burden which can contribute to an increase in quality of life scores.
Education level and quality of life. There was statistical significance in all five quality
of life categories; total, environmental, physical health, psychological health, social
relationships. Individuals who received a bachelor degree (or higher) reported increased quality
of life scores when compared to individuals with an associates degree and individuals with a
high school diploma (or lower). Given the significance found in this demographic category,
further studies may be warranted to evaluate the potential reasons for significant differences
found in quality of life across various education levels. Consideration for evaluation of
socioeconomic status in conjunction with education level may be beneficial in drawing further
conclusions.
Limitations
Some unforeseen limitations during the data collection period of the study include world
events such as the COVID-19 pandemic. The presence of these worldly events could have
unintentionally impacted overall quality of life scores. For example, COVID-19 may have
caused decreased quality of life in this patient population as a whole as ESRD patients are at a
higher risk for complications from the virus.
Additionally, and as previously described, BMI was calculated via participant reported
height and weight. This is a limitation because previous literature has shown that waist
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circumference is a better predictor of obesity in this population and is more strongly associated
with quality of life in ESRD patients (Beberashvili et al., 2019). Also, in an effort to maintain
validity of the study, the researchers thoroughly examined each individual's BMI and eliminated
one participant from the study due to an outlier value that was very likely an inaccurate BMI.
The population, platform, and survey tool were intentionally set in order to narrow the
scope of the study and for consistency of results. The collection of demographic information also
served to identify potential confounding variables that may impact quality of life of participants;
specifically age, gender, country of residence, marital status, and education level. While
delimitations constrained the extent of the study, limitations may have unintentionally impacted
the results of this study. Previously discussed limitations including response bias, possibility of
multiple responses from individuals, need for internet access, and belonging to a support group
continue to be acknowledged and should be considered a limitation.
Further Research
The results obtained in this study are consistent with the findings from the literature
review in Chapter Two. The comorbidity of diabetes in conjunction with ESRD was found to be
significant in that individuals with diabetes and ESRD reported an overall lower quality of life
score when compared to individuals with ESRD without diabetes. This finding could open up
possible avenues of research to explore if type one versus type two diabetes, glycemic control,
and/or the presence of other comorbidities associated with diabetes (e.g., retinopathy,
neuropathy) influence the quality of life of ESRD patients receiving hemodialysis.
The results of this study also concluded that the presence of obesity with ESRD resulted
in lower quality of life scores when compared to individuals with ESRD who were not obese.
Further avenues of research could include comparing more specific classes of weight (i.e.,
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underweight, normal, overweight, obese, and morbidly obese) to further assess significance of
BMI on quality of life among ESRD patients. There may be significant differences in quality of
life scores if obesity was further broken up into BMI sections, comparing BMI values rather than
doing not obese versus obese.
Additionally, further research could be conducted to evaluate the statistical findings from
the demographics section of the survey. For example, participants with bachelor’s degrees
reported a statistically significant increase in quality of life across all five domains when
compared to participants with an associate’s degree or less. Similarly, participants who are
married reported a statistically significant increase in quality of life in four of the five domains
when compared to unmarried participants. Additional research opportunities may lie in assessing
the relationship between participant demographics and their influence on the quality of life in
ESRD patients receiving hemodialysis.
Lastly, the most statistically significant domain in each of the different analyses was
found to be environmental factors. Further research into the environmental factors questions of
this survey may yield a greater understanding of why this area is so important to quality of life
among ESRD patients receiving hemodialysis.
Conclusion
This study aimed to explore the differences between comorbid diabetes and comorbid
obesity and their impact on quality of life in the ESRD patient population who receive
hemodialysis treatment. The results of this study were obtained through various support groups
on Facebook. Results of the study were collected and analyzed in an effort to determine what
relationship, if any, exists between the aforementioned comorbidities and quality of life. A
number of relationships were found within the data. Most notably, participants with comorbid
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diabetes reported a decreased quality of life among all five domains when compared to
participants with obesity and those with no comorbidities (i.e., the control group). In terms of
statistical significance, diabetes was found to have a decreased quality of life score when
compared to the control group in four of the five domains. Though diabetes and obesity yielded
statistically significant results when compared to the control group, when compared to each
other, neither comorbidity showed to be statistically significant in its impact on quality of life.
A review of study limitations and further research opportunities was also included within
the chapter. Worldly events such as the COVID-19 pandemic may have impacted the study in
unforeseeable ways. Discussion regarding study design and use of waist circumference instead of
BMI and further evaluation of severity of diabetes and obesity may be considered in the future.
The results of this study may be utilized to improve understanding of the ESRD patient
population and to shed light on the growing burden of disease. These findings can be used in an
effort to further support individuals with comorbid diabetes and/or obesity and may lead to
development of interventions aimed to improve quality of life in ESRD patients receiving
hemodialysis.
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APPENDIX B
Researcher Data Collection Script - Initial Facebook Post for the “Living With Kidney Failure End Stage Renal Disease (ESRD) Support Group” Facebook Group
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Hello, we are students from Bethel University’s Physician Assistant Program. We are
conducting research regarding quality of life in people receiving hemodialysis treatment. The
study consists of an online survey that asks questions about your demographic information and
quality of life. If you choose to proceed, the survey will take approximately 10 minutes to
complete. No confidential information will be collected. Your participation is entirely voluntary
and you can choose not to answer questions or discontinue participation at any time. Your
decision to participate or not to participate will not impact your relationship with Bethel
University or the “Living With Kidney Failure - End Stage Renal Disease (ESRD) Support
Group” Facebook group. Following completion of the study, all information collected will be
destroyed.

If you have any questions or difficulty with the survey link, please contact
bethelESRDresearch@gmail.com.
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APPENDIX C
Researcher Data Collection Script - Initial Facebook Post for the “Hemodialysis Support
Group”, “Dialysis and Kidney Disease Support Group”, and “Kidney Dialysis Support Group”
Facebook Pages
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Hello, we are students from Bethel University’s Physician Assistant Program. We are
conducting research regarding quality of life in people receiving hemodialysis treatment. The
study consists of an online survey that asks questions about your demographic information and
quality of life. If you choose to proceed, the survey will take approximately 10 minutes to
complete. No confidential information will be collected. Your participation is entirely voluntary
and you can choose not to answer questions or discontinue participation at any time. Your
decision to participate or not to participate will not impact your relationship with Bethel
University or the Facebook group. Following completion of the study, all information collected
will be destroyed.

If you have any questions or difficulty with the survey link, please contact
bethelESRDresearch@gmail.com.
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APPENDIX D
Researcher Data Collection Script - Initial Facebook Post for the National Kidney Foundation
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Hello, we are students from Bethel University’s Physician Assistant Program. We are
conducting research regarding quality of life in patients receiving hemodialysis treatment. The
study consists of an online survey that asks questions about your demographic information and
quality of life. If you choose to proceed, the survey will take approximately 10 minutes to
complete. No confidential information will be collected and no medical records are being
accessed. Your participation is entirely voluntary and you can choose not to answer questions or
discontinue participation at any time. Your decision to participate or not to participate will not
impact your relationship with Bethel University. Following completion of the study, any
information collected will be destroyed.

If you have any questions or difficulty with the survey link, please contact
bethelESRDresearch@gmail.com.
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APPENDIX E
Follow-Up Facebook Post for “Living With Kidney Failure - End Stage Renal Disease (ESRD)
Support Group” Facebook Group

103

Hello, again! If you are currently undergoing hemodialysis treatment and have not
participated in our study about quality of life, please consider taking the survey below. The
survey will take approximately 10 minutes to complete. No confidential information will be
collected. Your participation is entirely voluntary and you can choose not to answer questions or
discontinue participation at any time. Your decision to participate or not to participate will not
impact your relationship with Bethel University or the “Living With Kidney Failure - End Stage
Renal Disease (ESRD) Support Group” Facebook group. Following completion of the study, all
information collected will be destroyed.

If you have any questions or difficulty with the survey link, please contact
bethelESRDresearch@gmail.com.
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APPENDIX F
Follow-Up Facebook Post for “Hemodialysis Support Group”, “Dialysis and Kidney Disease
Support Group”, and “Kidney Dialysis Support Group” Facebook Pages
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Hello, again! If you are currently undergoing hemodialysis treatment and have not
participated in our study about quality of life, please consider taking the survey below. The
survey will take approximately 10 minutes to complete. No confidential information will be
collected. Your participation is entirely voluntary and you can choose not to answer questions or
discontinue participation at any time. Your decision to participate or not to participate will not
impact your relationship with Bethel University or the Facebook group. Following completion of
the study, all information collected will be destroyed.

If you have any questions or difficulty with the survey link, please contact
bethelESRDresearch@gmail.com.
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APPENDIX G
Follow-Up Facebook Post for NKF Facebook Page
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Hello, again! If you are currently undergoing hemodialysis treatment and have not
participated in our study about quality of life, please consider taking the survey below. The
survey will take approximately 10 minutes to complete. No confidential information will be
collected. Your participation is entirely voluntary and you can choose not to answer questions or
discontinue participation at any time. Your decision to participate or not to participate will not
impact your relationship with Bethel University. Following completion of the study, all
information collected will be destroyed.

If you have any questions or difficulty with the survey link, please contact
bethelESRDresearch@gmail.com.
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APPENDIX H
Survey Completion “Thank You” Page
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APPENDIX I
Demographic Information Questions
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APPENDIX J
IRB Approval
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APPENDIX K
IRB Addendum 1
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APPENDIX L
IRB Addendum 2
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APPENDIX M
Informed Consent for “Living With Kidney Failure - End Stage Renal Disease (ESRD) Support
Group” Facebook Group
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BETHEL UNIVERSITY PHYSICIAN ASSISTANT PROGRAM
INFORMED CONSENT
You have been identified as a potential participant and are invited to partake in the following
survey regarding quality of life. The study is designed to determine the relationship between
diabetes, obesity, and quality of life in patients with end-stage renal disease receiving
hemodialysis treatment. Researchers are students in Bethel University’s Physician Assistant
Program and are conducting this research in partial fulfillment of their master’s thesis.
Participation in the study is entirely voluntary and participants may withdraw from the study at
any time. If you choose to participate, the online demographic and quality of life survey will take
approximately 10 minutes to complete.
Data collected from surveys will not contain any identifiable information including: name, date
of birth, or medical record number. The sealed data will be stored at Bethel University and on
password protected computers belonging to researchers.
Your decision to participate and information gathered from the survey will not impact your
relationship with Bethel University or the “Living With Kidney Failure - End Stage Renal
Disease (ESRD) Support Group” Facebook group in any way.
If your participation in the study provokes feelings of anxiety or depression and you wish to seek
help, please contact the National Disaster Distress hotline at 1-800-985-5990.
This research project has been approved by Bethel University’s PA Program Director with
Bethel’s Levels of Review for Research with Humans. If you have any questions about the
research and/or research participants’ rights or wish to report a research-related injury, please
contact:
Austyn Cross (Researcher)
Hailey Shaull (Researcher)
Paige Urquhart (Researcher)
Lisa Naser (Bethel University Faculty Sponsor)
Wallace Boeve (Bethel University Faculty Sponsor)
By checking this box and completing the survey, you are granting consent to participate in this
research.
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APPENDIX N
Informed Consent for “Hemodialysis Support Group”, “Dialysis and Kidney Disease Support
Group”, and “Kidney Dialysis Support Group” Facebook Pages
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BETHEL UNIVERSITY PHYSICIAN ASSISTANT PROGRAM
INFORMED CONSENT
You have been identified as a potential participant and are invited to partake in the following
survey regarding quality of life. The study is designed to determine the relationship between
diabetes, obesity, and quality of life in patients with end-stage renal disease receiving
hemodialysis treatment. Researchers are students in Bethel University’s Physician Assistant
Program and are conducting this research in partial fulfillment of their master’s thesis.
Participation in the study is entirely voluntary and participants may withdraw from the study at
any time. If you choose to participate, the online demographic and quality of life survey will take
approximately 10 minutes to complete.
Data collected from surveys will not contain any identifiable information including: name, date
of birth, or medical record number. The sealed data will be stored at Bethel University and on
password protected computers belonging to researchers.
Your decision to participate and information gathered from the survey will not impact your
relationship with Bethel University or the Facebook group in any way.
If your participation in the study provokes feelings of anxiety or depression and you wish to seek
help, please contact the National Disaster Distress hotline at 1-800-985-5990.
This research project has been approved by Bethel University’s PA Program Director with
Bethel’s Levels of Review for Research with Humans. If you have any questions about the
research and/or research participants’ rights or wish to report a research-related injury, please
contact:
Austyn Cross (Researcher)
Hailey Shaull (Researcher)
Paige Urquhart (Researcher)
Lisa Naser (Bethel University Faculty Sponsor)
Wallace Boeve (Bethel University Faculty Sponsor)
By checking this box and completing the survey, you are granting consent to participate in this
research.
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APPENDIX O
Informed Consent for the National Kidney Foundation Facebook Group
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BETHEL UNIVERSITY PHYSICIAN ASSISTANT PROGRAM
INFORMED CONSENT
You have been identified as a potential participant and are invited to participate in the following
survey about quality of life. The objective of the study is to explore the relationship between
diabetes, obesity, and quality of life in people with end-stage renal disease who are receiving
hemodialysis treatment. Researchers are students in Bethel University’s Physician Assistant
Program.
Participation in the study is entirely voluntary and you may withdraw without repercussions at
any time by closing the Qualtrics browser or choosing to not answer all questions. If you choose
to participate, the online demographic and quality of life survey will take approximately 10
minutes to complete.
Data collected from surveys will not contain any identifiable information including: name or date
of birth. Participants and their responses will remain anonymous. The sealed data will be stored
at Bethel University and on password protected computers belonging to researchers.
Your decision to participate and information gathered from the survey will not impact your
relationship with Bethel University in any way.
If your participation in the study provokes feelings of anxiety or depression and you wish to seek
help, please contact the National Helpline at 1-800-662-HELP (4357).
This research project has been approved by Bethel University’s PA Program Director with
Bethel’s Levels of Review for Research with Humans. If you have any questions about the
research and/or research participants’ rights or wish to report a research-related injury, please
contact:
Austyn Cross (Researcher)
Hailey Shaull (Researcher)
Paige Urquhart (Researcher)
Lisa Naser (Bethel University Faculty Sponsor)
By checking this box and completing the survey, you are granting consent to participate in this
research.
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APPENDIX P
Approval for WHOQOL-BREF Use
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APPENDIX Q
WHOQOL-BREF Scoring
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